US20030013889A1 - Process for the preparation of taxane derivatives - Google Patents
Process for the preparation of taxane derivatives Download PDFInfo
- Publication number
- US20030013889A1 US20030013889A1 US10/179,027 US17902702A US2003013889A1 US 20030013889 A1 US20030013889 A1 US 20030013889A1 US 17902702 A US17902702 A US 17902702A US 2003013889 A1 US2003013889 A1 US 2003013889A1
- Authority
- US
- United States
- Prior art keywords
- radical
- carbon atoms
- chosen
- process according
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title claims abstract description 6
- 238000002360 preparation method Methods 0.000 title claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 59
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 23
- 150000003254 radicals Chemical group 0.000 claims abstract description 20
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 9
- 125000006239 protecting group Chemical group 0.000 claims abstract description 9
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims abstract description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 8
- 150000005840 aryl radicals Chemical class 0.000 claims abstract description 7
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 claims abstract description 6
- 125000005036 alkoxyphenyl group Chemical group 0.000 claims abstract description 6
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 3
- 125000003884 phenylalkyl group Chemical group 0.000 claims abstract description 3
- -1 alkyl radical Chemical class 0.000 claims description 98
- 239000002253 acid Substances 0.000 claims description 21
- 150000002148 esters Chemical class 0.000 claims description 20
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 239000003960 organic solvent Substances 0.000 claims description 14
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 13
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 13
- 125000005843 halogen group Chemical group 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 150000002576 ketones Chemical class 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 claims description 8
- OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 claims description 8
- 230000003213 activating effect Effects 0.000 claims description 8
- 150000008064 anhydrides Chemical class 0.000 claims description 8
- 230000032050 esterification Effects 0.000 claims description 8
- 238000005886 esterification reaction Methods 0.000 claims description 8
- 150000002170 ethers Chemical class 0.000 claims description 8
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 150000003927 aminopyridines Chemical class 0.000 claims description 6
- 125000004429 atom Chemical group 0.000 claims description 6
- RGUKYNXWOWSRET-UHFFFAOYSA-N 4-pyrrolidin-1-ylpyridine Chemical compound C1CCCN1C1=CC=NC=C1 RGUKYNXWOWSRET-UHFFFAOYSA-N 0.000 claims description 5
- 150000002826 nitrites Chemical class 0.000 claims description 5
- 229930014667 baccatin III Natural products 0.000 claims description 4
- 238000009833 condensation Methods 0.000 claims description 4
- 230000005494 condensation Effects 0.000 claims description 4
- ORTFAQDWJHRMNX-UHFFFAOYSA-M oxidooxomethyl Chemical compound [O-][C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-M 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- KZKRRZFCAYOXQE-UHFFFAOYSA-N 1$l^{2}-azinane Chemical compound C1CC[N]CC1 KZKRRZFCAYOXQE-UHFFFAOYSA-N 0.000 claims description 2
- CPEONABTMRSIKA-UHFFFAOYSA-N 1,4$l^{2}-oxazinane Chemical compound C1COCC[N]1 CPEONABTMRSIKA-UHFFFAOYSA-N 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 125000004423 acyloxy group Chemical group 0.000 claims description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 2
- QPOWUYJWCJRLEE-UHFFFAOYSA-N dipyridin-2-ylmethanone Chemical compound C=1C=CC=NC=1C(=O)C1=CC=CC=N1 QPOWUYJWCJRLEE-UHFFFAOYSA-N 0.000 claims description 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 claims description 2
- 150000003949 imides Chemical class 0.000 claims description 2
- 238000011065 in-situ storage Methods 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 abstract description 3
- 125000000304 alkynyl group Chemical group 0.000 abstract description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 78
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 51
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- 125000003118 aryl group Chemical group 0.000 description 39
- 239000000203 mixture Substances 0.000 description 36
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 28
- 0 *.*C(=O)N1[C@@H]([Ar])[C@H](C(=O)O[C@H]2C[C@@]3(O)[C@@H](OC(=O)C4=CC=CC=C4)[C@@]4([H])[C@](C)(C(=O)[C@H](O[3*])C(=C2C)C3(C)C)[C@@H](O[4*])C[C@H]2OC[C@]24OC(C)=O)OC1([1*])[2*].S Chemical compound *.*C(=O)N1[C@@H]([Ar])[C@H](C(=O)O[C@H]2C[C@@]3(O)[C@@H](OC(=O)C4=CC=CC=C4)[C@@]4([H])[C@](C)(C(=O)[C@H](O[3*])C(=C2C)C3(C)C)[C@@H](O[4*])C[C@H]2OC[C@]24OC(C)=O)OC1([1*])[2*].S 0.000 description 26
- 239000011541 reaction mixture Substances 0.000 description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 22
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 21
- 239000012074 organic phase Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- 238000001914 filtration Methods 0.000 description 14
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 230000008878 coupling Effects 0.000 description 13
- 238000010168 coupling process Methods 0.000 description 13
- 238000005859 coupling reaction Methods 0.000 description 13
- 238000002329 infrared spectrum Methods 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 12
- 239000011780 sodium chloride Substances 0.000 description 12
- 229910052938 sodium sulfate Inorganic materials 0.000 description 11
- 235000011152 sodium sulphate Nutrition 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 239000008346 aqueous phase Substances 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 10
- 239000000741 silica gel Substances 0.000 description 10
- 229910002027 silica gel Inorganic materials 0.000 description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 description 10
- 239000012300 argon atmosphere Substances 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 238000004809 thin layer chromatography Methods 0.000 description 9
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 8
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 8
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 8
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 8
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 8
- 238000001819 mass spectrum Methods 0.000 description 8
- KPGOCVKHOGAOJE-SLFFLAALSA-N 3-o-tert-butyl 5-o-methyl (2r,4s,5s)-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate Chemical compound C1([C@@H]2N([C@H](O[C@@H]2C(=O)OC)C=2C=CC(OC)=CC=2)C(=O)OC(C)(C)C)=CC=CC=C1 KPGOCVKHOGAOJE-SLFFLAALSA-N 0.000 description 7
- MSVWUXLRSKRKFZ-GBESFXJTSA-N (2r,4s,5s)-2-(4-methoxyphenyl)-3-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid Chemical compound C1=CC(OC)=CC=C1[C@@H]1N(C(=O)OC(C)(C)C)[C@@H](C=2C=CC=CC=2)[C@@H](C(O)=O)O1 MSVWUXLRSKRKFZ-GBESFXJTSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- NCALQERIBRYGOK-RYUDHWBXSA-N methyl (2s,3s)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoate Chemical compound CC(C)(C)OC(=O)N[C@H]([C@H](O)C(=O)OC)C1=CC=CC=C1 NCALQERIBRYGOK-RYUDHWBXSA-N 0.000 description 6
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229940063683 taxotere Drugs 0.000 description 6
- KPGOCVKHOGAOJE-UFYCRDLUSA-N 3-o-tert-butyl 5-o-methyl (2s,4s,5s)-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate Chemical compound C1([C@@H]2N([C@@H](O[C@@H]2C(=O)OC)C=2C=CC(OC)=CC=2)C(=O)OC(C)(C)C)=CC=CC=C1 KPGOCVKHOGAOJE-UFYCRDLUSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000001282 iso-butane Substances 0.000 description 5
- 239000001117 sulphuric acid Substances 0.000 description 5
- 235000011149 sulphuric acid Nutrition 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- MSVWUXLRSKRKFZ-IPMKNSEASA-N (2r,4s,5r)-2-(4-methoxyphenyl)-3-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid Chemical compound C1=CC(OC)=CC=C1[C@@H]1N(C(=O)OC(C)(C)C)[C@@H](C=2C=CC=CC=2)[C@H](C(O)=O)O1 MSVWUXLRSKRKFZ-IPMKNSEASA-N 0.000 description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- NNHYAHOTXLASEA-UHFFFAOYSA-N 1-(dimethoxymethyl)-4-methoxybenzene Chemical compound COC(OC)C1=CC=C(OC)C=C1 NNHYAHOTXLASEA-UHFFFAOYSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 4
- 241001024304 Mino Species 0.000 description 4
- 229930012538 Paclitaxel Natural products 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 4
- 229940011051 isopropyl acetate Drugs 0.000 description 4
- GWYFCOCPABKNJV-UHFFFAOYSA-M isovalerate Chemical compound CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- 229960001592 paclitaxel Drugs 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- 150000003738 xylenes Chemical class 0.000 description 4
- VAHXMEZCPGHDBJ-STQMWFEESA-N (4s,5s)-2,2-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid Chemical compound OC(=O)[C@H]1OC(C)(C)N(C(=O)OC(C)(C)C)[C@H]1C1=CC=CC=C1 VAHXMEZCPGHDBJ-STQMWFEESA-N 0.000 description 3
- AQOXAQNPPJHPAD-HOTGVXAUSA-N (4s,5s)-3-benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid Chemical compound N1([C@H]([C@H](OC1(C)C)C(O)=O)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 AQOXAQNPPJHPAD-HOTGVXAUSA-N 0.000 description 3
- JQJZUDSMRKCECN-KBPBESRZSA-N 3-o-tert-butyl 5-o-methyl (4s,5s)-2,2-dimethyl-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate Chemical compound COC(=O)[C@H]1OC(C)(C)N(C(=O)OC(C)(C)C)[C@H]1C1=CC=CC=C1 JQJZUDSMRKCECN-KBPBESRZSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 3
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 3
- RJXHUPPAAIRXHL-MSOLQXFVSA-N [(4s,5r)-5-ethenyl-2,2-dimethyl-4-phenyl-1,3-oxazolidin-3-yl]-phenylmethanone Chemical compound N1([C@H]([C@@H](C=C)OC1(C)C)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 RJXHUPPAAIRXHL-MSOLQXFVSA-N 0.000 description 3
- 125000004442 acylamino group Chemical group 0.000 description 3
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 125000004663 dialkyl amino group Chemical group 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- YOWQWFMSQCOSBA-UHFFFAOYSA-N 2-methoxypropene Chemical compound COC(C)=C YOWQWFMSQCOSBA-UHFFFAOYSA-N 0.000 description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 125000005107 alkyl diaryl silyl group Chemical group 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 125000005105 dialkylarylsilyl group Chemical group 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 239000008241 heterogeneous mixture Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 125000004665 trialkylsilyl group Chemical group 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- ZVAFCKLQJCZGAP-WDEREUQCSA-N (2r,3s)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H]([C@@H](O)C(O)=O)C1=CC=CC=C1 ZVAFCKLQJCZGAP-WDEREUQCSA-N 0.000 description 1
- ZVAFCKLQJCZGAP-QWRGUYRKSA-N (2s,3s)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H]([C@H](O)C(O)=O)C1=CC=CC=C1 ZVAFCKLQJCZGAP-QWRGUYRKSA-N 0.000 description 1
- VAHXMEZCPGHDBJ-QWHCGFSZSA-N (4s,5r)-2,2-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid Chemical compound OC(=O)[C@@H]1OC(C)(C)N(C(=O)OC(C)(C)C)[C@H]1C1=CC=CC=C1 VAHXMEZCPGHDBJ-QWHCGFSZSA-N 0.000 description 1
- AQOXAQNPPJHPAD-JKSUJKDBSA-N (4s,5r)-3-benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid Chemical compound N1([C@H]([C@@H](OC1(C)C)C(O)=O)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 AQOXAQNPPJHPAD-JKSUJKDBSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- KKFDJZZADQONDE-UHFFFAOYSA-N (hydridonitrato)hydroxidocarbon(.) Chemical compound O[C]=N KKFDJZZADQONDE-UHFFFAOYSA-N 0.000 description 1
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- AZSKVEYHTRTBCX-RYUDHWBXSA-N 4-o-tert-butyl 1-o-methyl (2s,3s)-2-hydroxy-3-phenylbutanedioate Chemical compound COC(=O)[C@@H](O)[C@@H](C(=O)OC(C)(C)C)C1=CC=CC=C1 AZSKVEYHTRTBCX-RYUDHWBXSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 238000006418 Brown reaction Methods 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229910019891 RuCl3 Inorganic materials 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000000719 anti-leukaemic effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 125000005239 aroylamino group Chemical group 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000005129 aryl carbonyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- CYKLGTUKGYURDP-UHFFFAOYSA-L copper;hydrogen sulfate;hydroxide Chemical compound O.[Cu+2].[O-]S([O-])(=O)=O CYKLGTUKGYURDP-UHFFFAOYSA-L 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- JEVCWSUVFOYBFI-UHFFFAOYSA-N cyanyl Chemical compound N#[C] JEVCWSUVFOYBFI-UHFFFAOYSA-N 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 125000005117 dialkylcarbamoyl group Chemical group 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- OQLKLXPKPPPXDZ-CVEARBPZSA-N n-[(1s,2r)-2-hydroxy-1-phenylbut-3-enyl]benzamide Chemical compound N([C@H]([C@@H](C=C)O)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 OQLKLXPKPPPXDZ-CVEARBPZSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- PJGSXYOJTGTZAV-UHFFFAOYSA-N pinacolone Chemical compound CC(=O)C(C)(C)C PJGSXYOJTGTZAV-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003303 ruthenium Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the present invention relates to a process for the preparation of taxane derivatives of general formula:
- Ar represents an aryl radical
- R represents the phenyl radical or a radical R 5 —O— in which R 5 represents
- a straight or branched alkyl radical containing 1 to 8 carbon atoms an alkenyl radical containing 2 to 8 carbon atoms, an alkynyl radical containing 3 to 8 carbon atoms, a cycloalkyl radical containing 3 to 6 carbon atoms, a cycloalkenyl radical containing 4 to 6 carbon atoms or a bicycloalkyl radical containing 7 to 11 carbon atoms, these radicals optionally being substituted by one or a number of substituents chosen from the halogen atoms and the hydroxyl radical, alkoxy radical containing 1 to 4 carbon atoms, dialkylamino radical, each alkyl part of which contains 1 to 4 carbon atoms, piperidino radical, morpholino radical, 1-piperazinyl radical (optionally substituted in the 4-position by an alkyl radical containing 1 to 4 carbon atoms or by a phenylalkyl radical, the alkyl part of which contains 1 to 4 carbon
- a phenyl radical optionally substituted by one or a number of atoms or radicals chosen from the halogen atoms and the alkyl radicals containing 1 to 4 carbon atoms or the alkoxy radicals containing 1 to 4 carbon atoms,
- a saturated or unsaturated nitrogen-containing heterocyclyl radical containing 4 to 6 members and optionally substituted by one or a number of alkyl radicals containing 1 to 4 carbon atoms it being understood that the cycloalkyl, cycloalkenyl or bicycloalkyl radicals may optionally be substituted by one or a number of alkyl radicals containing 1 to 4 carbon atoms,
- R 1 and R 2 which are identical or different, represent a hydrogen atom or an alkyl, phenylalkyl, phenyl, alkoxyphenyl or dialkoxyphenyl radical or else R 1 and R 2 form, together with the carbon atom to which they are bonded, a ring having from 4 to 7 members,
- R 3 represents an acetyl radical or a protective group of the hydroxyl functional group
- R 4 represents a protective group of the hydroxyl functional group.
- Ar represents a phenyl or ⁇ - or ⁇ -naphthyl radical optionally substituted by one or a number of atoms or radicals, identical or different, chosen from the halogen atoms (fluorine, chlorine, bromine, iodine) and the alkyl, alkenyl, alkynyl, aryl, aralkyl, alkoxy, alkylthio, aryloxy, arylthio, hydroxyl, hydroxyalkyl, mercapto, formyl, acyl, acylamino, aroylamino, alkoxycarbonylamino, amino, alkylamino, dialkylamino, carboxyl, alkoxycarbonyl, carbamoyl, dialkylcarbamoyl, cyano, nitro and trifluoromethyl radicals, it being understood that the alkyl radicals and the alkyl portions of the other radicals contain 1 to 4 carbon atoms or radicals, identical
- Ar represents a phenyl, 2- or 3-thienyl or 2- or 3-furyl radical optionally substituted by one or a number of atoms or radicals, which are identical or different, chosen from the halogen atoms and the alkyl, alkoxy, amino, dialkylamino, acylamino, alkoxycarbonylamino and trifluoromethyl radicals.
- Ar represents a phenyl radical optionally substituted by a chlorine or fluorine atom or by an alkyl (methyl), alkoxy (methoxy), dialkylamino (dimethylamino), acylamino (acetylamino) or alkoxycarbonylamino (t-butoxycarbonylamino) or 2- or 3-thienyl or 2- or 3-furyl radical.
- R 3 represents an acetyl radical or a protective group of the hydroxyl functional group chosen from the (2,2,2-trichloroethoxy)carbonyl, (2-trichloromethylisopropoxy)carbonyl, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl or triarylsilyl radicals in which the alkyl radicals contain 1 to 4 carbon atoms and the aryl radicals are, preferably, phenyl radicals and R 4 represents a protective group of the hydroxyl functional group chosen from the (2,2,2-trichloroethoxy)carbonyl, (2-trichloromethylisopropoxy)carbonyl, benzyl, 4-methoxybenzyl, 2,4-dimethoxybenzyl, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl or triarylsilyl radicals in which the alkyl radicals contain 1 to 4 carbon atom
- R 6 represents a hydrogen atom or the acetyl radical and R represents the phenyl radical or a radical R 5 —O— in which R 5 is defined as above, by passing through the intermediacy of a product of general formula:
- the esterification of protected baccatin III or protected 10-deacetylbaccatin III by the acid of general formula (VI) is carried out in the presence of a condensation agent such as an imide, such as dicyclohexylcarbodiimide, or a reactive carbonate, such as di-2-pyridyl ketone, and of an activating agent such as an aminopyridine, such as 4-dimethylaminopyridine or 4-pyrrolidinopyridine, the reaction being carried out in an organic solvent chosen from ethers such as tetrahydrofuran, diisopropyl ether, methyl t-butyl ether or dioxane, ketones such as methyl isobutyl ketone, esters such as ethyl acetate, isopropyl acetate or n-butyl acetate, nitriles, aliphatic hydrocarbons such as pentane, hexane or h
- a condensation agent such as an
- esterification can also be carried out by using the acid of general formula (VI) in the anhydride form of general formula:
- an activating agent such as an aminopyridine, such as 4-dimethylaminopyridine or 4-pyrrolidinopyridine
- the reaction being carried out in an organic solvent chosen from ethers such as tetrahydrofuran, diisopropyl ether, methyl t-butyl ether or dioxane, ketones such as methyl isobutyl ketone, esters such as ethyl acetate, isopropyl acetate or n-butyl acetate, nitriles such as aectonitrile, aliphatic hydrocarbons such as pentane, hexane or heptane, halogenated aliphatic hydrocarbons such as dichloromethane or 1,2-dichloroethane and aromatic hydrocarbons such as benzene, toluene, xylenes, ethylbenzen
- an organic solvent chosen from ethers such as tetrahydrofuran, di
- esterification can also be carried out by using the acid of general formula (VI) in the halide or mixed anhydride form of general formula:
- X represents a halogen atom or an acyloxy or aroyloxy radical, optionally prepared in situ, in the presence of a base which is preferably a nitrogenous organic base such as a tertiary aliphatic amine, a pyridine or an aminopyridine, such as 4-dimethylaminopyridine or 4-pyrrolidinopyridine, the reaction being carried out in an inert organic solvent chosen from ethers such as tetrahydrofuran, diisopropyl ether, methyl t-butyl ether or dioxane, ketones such as methyl t-butyl ketone, esters such as ethyl acetate, isopropyl acetate or n-butyl acetate, nitriles such as acetonitrile, aliphatic hydrocarbons such as pentane, hexane or heptan
- a base which is preferably a nitrogenous organic base such as a
- the acid of general formula (VI) can be obtained by saponification of the ester of general formula:
- R, R 1 and R 2 are defined as above and R 7 represents an alkyl radical containing 1 to 4 carbon atoms optionally substituted by one or a number of phenyl radicals.
- the saponification is carried out in aqueous medium, optionally in the presence of an aliphatic alcohol containing 1 to 4 carbon atoms (methanol, ethanol, isopropanol, t-butanol), in the presence of an inorganic base chosen from hydroxides, carbonates or bicarbonates of-alkali metals or alkaline-earth metals, at a temperature between 0 and 50° C., preferably in the region of 20° C.
- an aliphatic alcohol containing 1 to 4 carbon atoms methanol, ethanol, isopropanol, t-butanol
- an inorganic base chosen from hydroxides, carbonates or bicarbonates of-alkali metals or alkaline-earth metals
- ester of general formula (IX) can be obtained by reacting an aldehyde or a ketone of general formula:
- R 1 and R 2 are defined as above, optionally in the form of a dialkyl acetal or of an enol alkyl ether, with an ester of general formula:
- ester of general formula (XI) can be obtained by reacting benzoyl chloride or a product of general formula R 5 —O—CO—Y, in which R 5 is defined as above and Y represents a halogen atom or a radical —O—R 5 or —O—CO—R 5 , with an ester of general formula:
- reaction being carried out in an organic solvent such as an aliphatic ester, such as ethyl acetate, or a halogenated aliphatic hydrocarbon such as dichloromethane, optionally in the presence of an inorganic base such as sodium bicarbonate or an organic base such as triethylamine.
- organic solvent such as an aliphatic ester, such as ethyl acetate, or a halogenated aliphatic hydrocarbon such as dichloromethane
- an inorganic base such as sodium bicarbonate or an organic base such as triethylamine.
- the reaction is carried out at a temperature between 0 and 50° C., preferably in the region of 20° C.
- ester of general formula (XII) can be obtained according to the process described by E. Kamandi et al., Arch. Pharmaz., 308, 135-141 (1975).
- the anhydride of general formula (VII) can be obtained by reacting a dehydrating agent such as dicyclohexylcarbodiimide with the acid of general formula (VI), the reaction being carried out in an organic solvent chosen from ethers such as tetrahydrofuran, diisopropyl ether, methyl t-butyl ether or dioxane, ketones such as methyl isobutyl ketone, esters such as ethyl acetate, isopropyl acetate or n-butyl acetate, nitrites such as acetonitrile, aliphatic hydrocarbons such as pentane, hexane or heptane, halogenated aliphatic hydrocarbons such as dichloromethane or 1,2-dichloroethane and aromatic hydrocarbons such as benzene, toluene, xylenes, ethylbenzene, isopropylbenz
- the activated acid of general formula (VIII) can be obtained by reacting a sulphuryl halide, preferably the chloride, or a product of general formula:
- R 8 represents an alkyl radical containing 1 to 4 carbon atoms or a phenyl radical optionally substituted by 1 to 5 atoms or radicals, which are identical or different, chosen from the halogen atoms and the nitro, methyl or methoxy radicals and Z represents a halogen atom, preferably a chlorine atom, with an acid of general formula (VI), the reaction being carried out in a suitable organic solvent, such as tetrahydrofuran, in the presence of an organic base such as a tertiary amine, such as triethylamine, at a temperature between 0 and 30° C.
- a suitable organic solvent such as tetrahydrofuran
- an organic base such as a tertiary amine, such as triethylamine
- the acid of general formula (VI) can also be obtained by oxidation of a product of general formula:
- the oxidation is carried out by means of an alkali metal periodate (sodium periodate), in the presence of a catalytic amount of a ruthenium salt (RuCl 3 ) and of sodium bicarbonate, the reaction being carried out in aqueous/organic medium such as, for example, an acetonitrile/carbon tetrachloride/water mixture.
- aqueous/organic medium such as, for example, an acetonitrile/carbon tetrachloride/water mixture.
- the reaction is carried out at a temperature in the region of 20° C.
- the product of general formula (XIV) can be obtained by reacting an aldehyde or a ketone of general formula (X), optionally in the form of a dialkyl acetal or of an enol ester, with a product of general formula:
- reaction being carried out in an inert organic solvent in the presence of a strong inorganic acid, such as sulphuric acid, or a strong organic acid, such as p-toluenesulphonic acid, optionally in the pyridinium salt form, at a temperature between 0° C. and the boiling temperature of the reaction mixture.
- a strong inorganic acid such as sulphuric acid
- a strong organic acid such as p-toluenesulphonic acid
- Solvents which are particularly well suited are aromatic hydrocarbons.
- ester of general formula (IX), in which Ar and R 7 are defined as above, R 1 represents a hydrogen atom and R 2 represents a phenyl, alkoxyphenyl or dialkoxyphenyl radical, can also be obtained by cyclization of a product of general formula:
- Ar, R and R 7 are defined as above and Ph represents a phenyl, alkoxyphenyl or dialkoxyphenyl radical
- the reaction preferably being carried out in anhydrous medium, in an organic solvent chosen from ethers, esters, ketones, nitrites, optionally halogenated aliphatic hydrocarbons and optionally halogenated aromatic hydrocarbons in the presence of an oxidizing agent such as dichlorodicyanobenzoquinone at a temperature between 0° C. and the boiling temperature of the reaction mixture.
- the reaction is preferably carried out in an halogenated-aliphatic hydrocarbon, such as dichloromethane, or acetonitrile at a temperature in the region of 20° C.
- the cyclization leads to the formation of a mixture of 2R and 2S epimers of the product of general formula (IX) which can be separated according to the usual methods. It is particularly advantageous to preferentially obtain the 2R epimer in order to prepare taxol, Taxotere or their derivatives from a product of general formula (I).
- the invention also relates to the acids of general formula (VI), optionally in the salt, ester, anhydride, mixed anhydride or halide form.
- the taxane derivatives of general formula (I) obtained by the use of the process according to the invention can be converted to taxol, Taxotere or their analogues according to the processes described in International Application PCT WO 9209589, when R 1 and R 2 each represent an alkyl or phenylalkyl radical by passing through the intermediacy of the product of general formula (V) or else by treatment in acid medium (hydrochloric acid, sulphuric acid, acetic acid, methanesulphonic acid, trifluoromethanesulphonic acid, p-toluenesulphonic acid), the reaction being carried out in an organic solvent (alcohol, ether, ester, aliphatic hydrocarbon, halogenated aliphatic hydrocarbon, aromatic hydrocarbon, nitrile) at a temperature between ⁇ 10 and 60° C., or, when R 1 represents a hydrogen atom and R 2 represents a phenyl, alkoxyphenyl or dialkoxyphenyl radical,
- R and Ph are defined as above and R′ represents a hydrogen atom or the acetyl radical, after replacement of the protective groups R 4 and optionally R 3 by hydrogen atoms according to known methods.
- infrared spectrum (film): main characteristic absorption bands at 3450, 2970, 2910, 1760, 1720, 1700, 1600, 1580, 1450, 1375, 1360, 1245, 1170, 1135, 1100, 1080, 1060, 1020, 995, 975, 960, 900, 820, 765 and 720 cm ⁇ 1
- (4S,5S)-3-t-Butoxycarbonyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid can be prepared in the following way:
- the basic aqueous phase is cooled to 0° C. and is then acidified, in the presence of 20 cm 3 of dichloromethane and with vigorous stirring, by addition of a 2M aqueous hydrochloric acid solution.
- the organic phase is separated by settling and the aqueous phase is then extracted 6 times with 30 cm 3 of dichloromethane.
- the combined organic phases are washed 3 times with 5 cm 3 of distilled water, then once with 5 cm 3 of a saturated aqueous sodium chloride solution and then finally dried over anhydrous magnesium sulphate.
- infrared spectrum (film): main characteristic absorption bands at 3650-2200, 2970, 2920, 1760, 1740, 1700, 1470, 1450, 1370, 1250, 1215, 1165, 1135, 1110, 1065, 875 and 690 cm ⁇ 1
- (4S,5S)-3-t-Butoxycarbonyl-2,2-dimethyl-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine can be prepared in the following way:
- infrared spectrum (film): main characteristic absorption bands at 3060, 3025, 2975, 2920, 1775, 1740, 1700, 1490, 1480, 1450, 1440, 1365, 1250, 1210, 1165, 1110, 1070, 1050, 1030, 890, 760, 720 and 695 cm ⁇ 1
- Methyl (2S,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate can be prepared in the following way:
- a 4N aqueous sodium hydroxide solution is added, over 5 minutes, to a suspension of 6.5 g of ⁇ -methylbenzylamine (2S,3R)-phenylglycidate in 20 cm 3 of toluene and 10 cm 3 of water. After stirring for 2 hours at a temperature in the region of 20° C., the separated aqueous phase is extracted with 2 times 7 cm 3 of toluene. The aqueous phase is introduced into an autoclave. After having added 97.5 cm 3 of a 32% (w/v) aqueous ammonia solution and 1.22 g of ammonium chloride, the autoclave is closed and then heated, with stirring, for 6 hours at 60° C.
- infrared spectrum (film): main characteristic absorption bands at 3380, 3350, 3000, 2970, 2930, 1720, 1690, 1510, 1435, 1385, 1360, 1310, 1285, 1230, 1205, 1170, 1105, 1005, 860, 770, 750, 730 and 690 cm ⁇ 1
- the reaction mixture is diluted by addition of 40 cm 3 of ethyl acetate.
- the organic phase is washed with 2 times 5 cm 3 of a saturated aqueous sodium bicarbonate solution, 3 times 5 cm 3 of water, then once with 5 cm 3 of a saturated aqueous sodium chloride solution and is finally dried over anhydrous sodium sulphate.
- the residue obtained (21 mg) is purified by silica thin layer chromatography, eluting with an ethyl ether/dichloromethane (8/92 by volume) mixture over two passes.
- infrared spectrum (film): main characteristic absorption bands at 3400, 2930, 2850, 1730, 1720, 1630, 1590, 1570, 1440, 1360, 1340, 1230, 1195, 1065, 1015, 1005, 980 and 810 cm ⁇ 1
- (4S,5S)-3-Benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid can be prepared in the following way:
- the reaction mixture is diluted in 10 cm 3 of water.
- the basic organic phase obtained is washed with 3 times 10 cm 3 of ether.
- the acidic aqueous phase is extracted with 6 times 15 cm 3 of dichloromethane.
- the combined organic phases are washed 3 times with 5 cm 3 of water and then once with 5 cm 3 of a saturated aqueous sodium chloride solution. After drying over anhydrous sodium sulphate and filtration, the organic phase is concentrated to dryness under reduced pressure.
- infrared spectrum film: main characteristic absorption bands at 3700-2300, 2970, 2940, 2930, 2900, 2825, 1740, 1600, 1590, 1570, 1420-1400, 1370, 1360, 1190, 1180, 1150, 1120, 1090 and 855 cm ⁇ 1
- the resulting reaction mixture is allowed to react at a temperature in the region of 15° C. for 2.5 hours and is then heated at 100° C. for 2 hours. After cooling to a temperature in the region of 15° C., the reaction mixture is diluted in 40 cm 3 of dichloromethane. The organic phase is washed once with 5 cm 3 of a saturated sodium bicarbonate solution, 3 times with 5 cm 3 of water and once with a saturated aqueous sodium chloride solution and is then dried over anhydrous sodium sulphate.
- infrared spectrum (film): main characteristic absorption bands at 3050, 3010, 2980, 2920, 1635, 1595, 1570, 1490, 1385, 1370, 1355, 1245, 1215, 1145, 1065, 1030, 1020, 935, 850 and 690 cm ⁇ 1
- infrared spectrum film: main characteristic absorption bands at 3500, 2950, 2900, 1760, 1730, 1720, 1700, 1605, 1580, 1505, 1380, 1375, 1360, 1240, 1140, 1060, 815, 760 and 710 cm ⁇ 1
- infrared spectrum film: characteristic absorption bands at 3430, 2960, 2880, 2840, 1730, 1720, 1700, 1685, 1605, 1580, 1505, 1440, 1380, 1360, 1340, 1265, 1240, 1170, 1130, 1060, 1015, 975, 905, 720 and 695 cm ⁇ 1
- the organic phase separated by settling, is washed with 3 times 5 cm 3 of water and once with 5 cm 3 of a saturated aqueous sodium chloride solution and is then dried over anhydrous sodium sulphate. After filtration and concentration to dryness under reduced pressure, the residue obtained is purified by silica gel thin layer chromatography, eluting with a methanol/dichloromethane (5/95 by volume) mixture.
- Taxotere thus obtained has the following characteristics:
- infrared spectrum film: main characteristic absorption bands at 3450, 3100, 3050, 2950, 2920, 2890, 2850, 1730, 1710, 1600, 1580, 1490, 1450, 1390, 1370, 1315, 1270, 1245, 1160, 1105, 1095, 1070, 1020, 980, 910, 730 and 710 cm ⁇ 1
- the basic aqueous phase is diluted in 10 cm 3 of water and then extracted with 3 times 15 cm 3 of ether.
- the aqueous phase is cooled to 0° C. and is then acidified, with vigorous stirring in the presence of 20 cm 3 of dichloromethane, with a 4M aqueous hydrochloric acid solution to-a pH of less than 1.
- the acidic aqueous phase is extracted 8 times with 20 cm 3 dichloromethane.
- the combined organic phases are washed with 3 times 5 cm 3 of water and then once with 5 cm 3 of a saturated aqueous sodium chloride solution.
- the organic phases are dried over anhydrous sodium sulphate.
- infrared spectrum film: main characteristic absorption bands at 3700-2300, 2950, 2900, 2820, 1755, 1700, 1605, 1580, 1505, 1385, 1360, 1300, 1285, 1240, 1215, 1165, 1130, 1075, 1065, 1020, 930, 900, 850, 820 and 685 cm ⁇ 1
- (2R,4S,5S)-3-t-Butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine can be prepared according to one of the following methods:
- the reaction mixture which has become homogeneous, is heated at reflux of the solvent for 5 minutes. After cooling to a temperature in the region of 20° C., the reaction mixture is diluted in 30 cm 3 of dichloromethane.
- the organic phase is treated once with 5 cm 3 of a saturated aqueous sodium bicarbonate solution and then washed with 2 times 5 cm 3 of water and once with 5 cm 3 of a saturated aqueous sodium chloride solution. After drying over anhydrous sodium sulphate, filtration and concentration to dryness under reduced pressure, the residue is purified by silica gel thin layer chromatography, eluting with an ethyl ether/hexane (6/4 by volume) mixture.
- esters can be separated by chromatography on a column of silica gel, eluting with an ethyl ether/hexane (2/8 by volume) mixture.
- (2R,4S,5S)-3-t-Butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine has the following characteristics:
- infrared spectrum (film): 2950, 1725, 1680, 1600, 1575, 1500, 1380, 1350, 1280, 1260, 1240, 1200, 1160, 1120, 1065, 1050, 1030 and 1010 cm ⁇ 1
- (2S,4S,5S)-3-t-Butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine has the following characteristics:
- infrared spectrum film: main characteristic absorption bands at 2950, 2900, 1760, 1730, 1695, 1600, 1580, 1505, 1450, 1430, 1380, 1360, 1335, 1290, 1240, 1210, 1160, 1150, 1080, 1030, 1020, 920, 801 and 680 cm ⁇ 1
- reaction mixture After cooling to a temperature in the region of 20° C., the reaction mixture is diluted in 30 cm 3 of dichloromethane.
- the organic phase is treated once with 5 cm 3 of a saturated aqueous sodium bicarbonate solution, then washed with 3 times with 5 cm 3 of water and once with 5 cm 3 of a saturated aqueous sodium chloride solution.
- reaction mixture is diluted in 30 cm 3 dichloromethane.
- the organic phase is treated once with 5 cm 3 of a saturated aqueous sodium bicarbonate solution, then washed 2 times with 5 cm 3 of water and once with 5 cm 3 of a saturated aqueous sodium chloride solution.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
are disclosed. In general formula (I), Ar represents an aryl radical; R represents a phenyl radical or a radical R5—O— in which R5 represents an alkyl, alkenyl, alkynyl, cycloalkyl, phenyl or saturated or unsaturated nitrogenous heterocylcyl radical, R1 and R2, which are identical or different, each represent a hydrogen atom or an alkyl, phenylalkyl, phenyl, alkoxyphenyl, or dialkoxyphenyl radical, or else R1 and R2 form, together with the carbon atom to which they are bonded, a ring having from 4 to 7 members; R3 represents an acetyl radical or a protecting group of the hydroxyl functional group; and R4 represents a protecting group of the hydroxyl functional group.
Description
-
- which are particularly advantageous intermediates for preparing taxol, Taxotere and their analogues which have notable antileukaemic and antitumour properties.
- In the general formula (I),
- Ar represents an aryl radical,
- R represents the phenyl radical or a radical R 5—O— in which R5 represents
- a straight or branched alkyl radical containing 1 to 8 carbon atoms, an alkenyl radical containing 2 to 8 carbon atoms, an alkynyl radical containing 3 to 8 carbon atoms, a cycloalkyl radical containing 3 to 6 carbon atoms, a cycloalkenyl radical containing 4 to 6 carbon atoms or a bicycloalkyl radical containing 7 to 11 carbon atoms, these radicals optionally being substituted by one or a number of substituents chosen from the halogen atoms and the hydroxyl radical, alkoxy radical containing 1 to 4 carbon atoms, dialkylamino radical, each alkyl part of which contains 1 to 4 carbon atoms, piperidino radical, morpholino radical, 1-piperazinyl radical (optionally substituted in the 4-position by an alkyl radical containing 1 to 4 carbon atoms or by a phenylalkyl radical, the alkyl part of which contains 1 to 4 carbon atoms), cycloalkyl radical containing 3 to 6 carbon atoms, cycloalkenyl radical containing 4 to 6 carbon atoms, phenyl cyano radical, carboxyl radical or alkoxycarbonyl radical, the alkyl part of which contains 1 to 4 carbon atoms,
- or a phenyl radical optionally substituted by one or a number of atoms or radicals chosen from the halogen atoms and the alkyl radicals containing 1 to 4 carbon atoms or the alkoxy radicals containing 1 to 4 carbon atoms,
- a saturated or unsaturated nitrogen-containing heterocyclyl radical containing 4 to 6 members and optionally substituted by one or a number of alkyl radicals containing 1 to 4 carbon atoms, it being understood that the cycloalkyl, cycloalkenyl or bicycloalkyl radicals may optionally be substituted by one or a number of alkyl radicals containing 1 to 4 carbon atoms,
- R 1 and R2, which are identical or different, represent a hydrogen atom or an alkyl, phenylalkyl, phenyl, alkoxyphenyl or dialkoxyphenyl radical or else R1 and R2 form, together with the carbon atom to which they are bonded, a ring having from 4 to 7 members,
- R 3 represents an acetyl radical or a protective group of the hydroxyl functional group and
- R 4 represents a protective group of the hydroxyl functional group.
- More particularly, Ar represents a phenyl or α- or β-naphthyl radical optionally substituted by one or a number of atoms or radicals, identical or different, chosen from the halogen atoms (fluorine, chlorine, bromine, iodine) and the alkyl, alkenyl, alkynyl, aryl, aralkyl, alkoxy, alkylthio, aryloxy, arylthio, hydroxyl, hydroxyalkyl, mercapto, formyl, acyl, acylamino, aroylamino, alkoxycarbonylamino, amino, alkylamino, dialkylamino, carboxyl, alkoxycarbonyl, carbamoyl, dialkylcarbamoyl, cyano, nitro and trifluoromethyl radicals, it being understood that the alkyl radicals and the alkyl portions of the other radicals contain 1 to 4 carbon atoms, that the alkenyl and alkynyl radicals contain 3 to 8 carbon atoms and that the aryl radicals are phenyl or α- or β-naphthyl radicals, or else Ar represents an aromatic heterocyclic radical having 5 members and containing one or a number of atoms, identical or different, chosen from the nitrogen, oxygen or sulphur atoms, optionally substituted by one or a number of substituents, identical or different, chosen from the halogen atoms (fluorine, chlorine, bromine, iodine) and the alkyl radicals containing 1 to 4 carbon atoms, aryl radicals containing 6 to 10 carbon atoms, alkoxy radical containing 1 to 4 carbon atoms, aryloxy radical containing 6 to 10 carbon atoms, amino radical, alkylamino radical containing 1 to 4 carbon atoms, dialkylamino radical, in which each alkyl part contains 1 to 4 carbon atoms, acylamino radical, the acyl part of which contains 1 to 4 carbon atoms, alkoxycarbonylamino radical containing 1 to 4 carbon atoms, acyl radical containing 1 to 4 carbon atoms, arylcarbonyl, the aryl part of which contains 6 to 10 carbon atoms, cyano radical, carboxyl radical, carbamoyl radical, alkylcarbamoyl radical, the alkyl part of which contains 1 to 4 carbon atoms, dialkylcarbamoyl radical, each alkyl part of which contains 1 to 4 carbon atoms, or alkoxycarbonyl radical, the alkoxy part of which contains 1 to 4 carbon atoms.
- More particularly, Ar represents a phenyl, 2- or 3-thienyl or 2- or 3-furyl radical optionally substituted by one or a number of atoms or radicals, which are identical or different, chosen from the halogen atoms and the alkyl, alkoxy, amino, dialkylamino, acylamino, alkoxycarbonylamino and trifluoromethyl radicals.
- More particularly still, Ar represents a phenyl radical optionally substituted by a chlorine or fluorine atom or by an alkyl (methyl), alkoxy (methoxy), dialkylamino (dimethylamino), acylamino (acetylamino) or alkoxycarbonylamino (t-butoxycarbonylamino) or 2- or 3-thienyl or 2- or 3-furyl radical.
- More particularly, R 3 represents an acetyl radical or a protective group of the hydroxyl functional group chosen from the (2,2,2-trichloroethoxy)carbonyl, (2-trichloromethylisopropoxy)carbonyl, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl or triarylsilyl radicals in which the alkyl radicals contain 1 to 4 carbon atoms and the aryl radicals are, preferably, phenyl radicals and R4 represents a protective group of the hydroxyl functional group chosen from the (2,2,2-trichloroethoxy)carbonyl, (2-trichloromethylisopropoxy)carbonyl, benzyl, 4-methoxybenzyl, 2,4-dimethoxybenzyl, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl or triarylsilyl radicals in which the alkyl radicals contain 1 to 4 carbon atoms and the aryl radicals are, preferably, phenyl radicals.
-
-
-
-
- in which R 3 and R4 are defined as above.
- According to the previously known processes, it was necessary, to obtain the products of general formula (IV), in which the absolute configuration of the side chain is necessary for the antitumoral activity, to use the acid of general formula (III) in which the carbon atoms in the 4- and 5-positions respectively have the S and R configurations.
- It has now been found, and it is this which forms the subject of the present invention, that the products of general formula (I) can be obtained, with a stereoselectivity in the region of 100%, by esterification of protected baccatin III or protected 10-deacetylbaccatin III by means of an acid of general formula:
- in which Ar, R, R 1 and R2 are defined as above and in which the carbon atoms in the 4- and 5-positions each have the S configuration, or of an activated derivative of this acid.
- The process according to the invention makes it possible to stereoselectively obtain the product of general formula (I) from an acid of general formula (VI), optionally mixed with an acid of general formula (III).
- According to the present invention, the esterification of protected baccatin III or protected 10-deacetylbaccatin III by the acid of general formula (VI) is carried out in the presence of a condensation agent such as an imide, such as dicyclohexylcarbodiimide, or a reactive carbonate, such as di-2-pyridyl ketone, and of an activating agent such as an aminopyridine, such as 4-dimethylaminopyridine or 4-pyrrolidinopyridine, the reaction being carried out in an organic solvent chosen from ethers such as tetrahydrofuran, diisopropyl ether, methyl t-butyl ether or dioxane, ketones such as methyl isobutyl ketone, esters such as ethyl acetate, isopropyl acetate or n-butyl acetate, nitriles, aliphatic hydrocarbons such as pentane, hexane or heptane, halogenated aliphatic hydrocarbons such as dichloromethane or 1,2-dichloroethane and aromatic hydrocarbons such as benzene, toluene, xylenes, ethylbenzene, isopropylbenzene or chlorobenzene, at a temperature between 0 and 90° C.
-
- in which Ar, R, R 1 and R2 are defined as above, in the presence of an activating agent such as an aminopyridine, such as 4-dimethylaminopyridine or 4-pyrrolidinopyridine, the reaction being carried out in an organic solvent chosen from ethers such as tetrahydrofuran, diisopropyl ether, methyl t-butyl ether or dioxane, ketones such as methyl isobutyl ketone, esters such as ethyl acetate, isopropyl acetate or n-butyl acetate, nitriles such as aectonitrile, aliphatic hydrocarbons such as pentane, hexane or heptane, halogenated aliphatic hydrocarbons such as dichloromethane or 1,2-dichloroethane and aromatic hydrocarbons such as benzene, toluene, xylenes, ethylbenzene, isopropylbenzene or chlorobenzene, at a temperature between 0 and 90° C.
-
- in which Ar, R, R 1 and R2 are defined as above and X represents a halogen atom or an acyloxy or aroyloxy radical, optionally prepared in situ, in the presence of a base which is preferably a nitrogenous organic base such as a tertiary aliphatic amine, a pyridine or an aminopyridine, such as 4-dimethylaminopyridine or 4-pyrrolidinopyridine, the reaction being carried out in an inert organic solvent chosen from ethers such as tetrahydrofuran, diisopropyl ether, methyl t-butyl ether or dioxane, ketones such as methyl t-butyl ketone, esters such as ethyl acetate, isopropyl acetate or n-butyl acetate, nitriles such as acetonitrile, aliphatic hydrocarbons such as pentane, hexane or heptane, halogenated aliphatic hydrocarbons such as dichloromethane or 1,2-dichloroethane and aromatic hydrocarbons such as benzene, toluene, xylenes, ethylbenzene, isopropylbenzene or chlorobenzene, at a temperature between 0 and 90° C.
-
- in which Ar, R, R 1 and R2 are defined as above and R7 represents an alkyl radical containing 1 to 4 carbon atoms optionally substituted by one or a number of phenyl radicals.
- Generally, the saponification is carried out in aqueous medium, optionally in the presence of an aliphatic alcohol containing 1 to 4 carbon atoms (methanol, ethanol, isopropanol, t-butanol), in the presence of an inorganic base chosen from hydroxides, carbonates or bicarbonates of-alkali metals or alkaline-earth metals, at a temperature between 0 and 50° C., preferably in the region of 20° C.
-
-
- in which Ar, R and R 7 are defined as above, the reaction being carried out in an inert organic solvent in the presence of a strong inorganic acid, such as sulphuric acid, or a strong organic acid, such as p-toluenesulphonic acid, optionally in the pyridinium salt form, at a temperature between 0° and the boiling temperature of the reaction mixture. Solvents which are particularly well suited are aromatic hydrocarbons such as toluene.
-
- in which Ar and R 7 are defined as above, the reaction being carried out in an organic solvent such as an aliphatic ester, such as ethyl acetate, or a halogenated aliphatic hydrocarbon such as dichloromethane, optionally in the presence of an inorganic base such as sodium bicarbonate or an organic base such as triethylamine. Generally, the reaction is carried out at a temperature between 0 and 50° C., preferably in the region of 20° C.
- The ester of general formula (XII) can be obtained according to the process described by E. Kamandi et al., Arch. Pharmaz., 308, 135-141 (1975).
- The anhydride of general formula (VII) can be obtained by reacting a dehydrating agent such as dicyclohexylcarbodiimide with the acid of general formula (VI), the reaction being carried out in an organic solvent chosen from ethers such as tetrahydrofuran, diisopropyl ether, methyl t-butyl ether or dioxane, ketones such as methyl isobutyl ketone, esters such as ethyl acetate, isopropyl acetate or n-butyl acetate, nitrites such as acetonitrile, aliphatic hydrocarbons such as pentane, hexane or heptane, halogenated aliphatic hydrocarbons such as dichloromethane or 1,2-dichloroethane and aromatic hydrocarbons such as benzene, toluene, xylenes, ethylbenzene, isopropylbenzene or chlorobenzene, at a temperature between 0 and 30° C.
- The activated acid of general formula (VIII) can be obtained by reacting a sulphuryl halide, preferably the chloride, or a product of general formula:
- R8—CO—Z (XIII)
- in which R 8 represents an alkyl radical containing 1 to 4 carbon atoms or a phenyl radical optionally substituted by 1 to 5 atoms or radicals, which are identical or different, chosen from the halogen atoms and the nitro, methyl or methoxy radicals and Z represents a halogen atom, preferably a chlorine atom, with an acid of general formula (VI), the reaction being carried out in a suitable organic solvent, such as tetrahydrofuran, in the presence of an organic base such as a tertiary amine, such as triethylamine, at a temperature between 0 and 30° C.
-
- in which Ar, R, R 1 and R2 are defined as above.
- Generally, the oxidation is carried out by means of an alkali metal periodate (sodium periodate), in the presence of a catalytic amount of a ruthenium salt (RuCl 3) and of sodium bicarbonate, the reaction being carried out in aqueous/organic medium such as, for example, an acetonitrile/carbon tetrachloride/water mixture. Generally, the reaction is carried out at a temperature in the region of 20° C.
-
- in which Ar and R are defined as above, the reaction being carried out in an inert organic solvent in the presence of a strong inorganic acid, such as sulphuric acid, or a strong organic acid, such as p-toluenesulphonic acid, optionally in the pyridinium salt form, at a temperature between 0° C. and the boiling temperature of the reaction mixture. Solvents which are particularly well suited are aromatic hydrocarbons.
- The product of general formula (XV) can be obtained under the conditions described in EP-A-0,530,385.
-
- in which Ar, R and R 7 are defined as above and Ph represents a phenyl, alkoxyphenyl or dialkoxyphenyl radical, the reaction preferably being carried out in anhydrous medium, in an organic solvent chosen from ethers, esters, ketones, nitrites, optionally halogenated aliphatic hydrocarbons and optionally halogenated aromatic hydrocarbons in the presence of an oxidizing agent such as dichlorodicyanobenzoquinone at a temperature between 0° C. and the boiling temperature of the reaction mixture. The reaction is preferably carried out in an halogenated-aliphatic hydrocarbon, such as dichloromethane, or acetonitrile at a temperature in the region of 20° C.
- The cyclization leads to the formation of a mixture of 2R and 2S epimers of the product of general formula (IX) which can be separated according to the usual methods. It is particularly advantageous to preferentially obtain the 2R epimer in order to prepare taxol, Taxotere or their derivatives from a product of general formula (I).
- The invention also relates to the acids of general formula (VI), optionally in the salt, ester, anhydride, mixed anhydride or halide form.
- The taxane derivatives of general formula (I) obtained by the use of the process according to the invention can be converted to taxol, Taxotere or their analogues according to the processes described in International Application PCT WO 9209589, when R 1 and R2 each represent an alkyl or phenylalkyl radical by passing through the intermediacy of the product of general formula (V) or else by treatment in acid medium (hydrochloric acid, sulphuric acid, acetic acid, methanesulphonic acid, trifluoromethanesulphonic acid, p-toluenesulphonic acid), the reaction being carried out in an organic solvent (alcohol, ether, ester, aliphatic hydrocarbon, halogenated aliphatic hydrocarbon, aromatic hydrocarbon, nitrile) at a temperature between −10 and 60° C., or, when R1 represents a hydrogen atom and R2 represents a phenyl, alkoxyphenyl or dialkoxyphenyl radical, by passing through the intermediacy of a product of general formula
- in which Ar, R and Ph are defined as above and R′ represents a hydrogen atom or the acetyl radical, after replacement of the protective groups R 4 and optionally R3 by hydrogen atoms according to known methods.
- The following examples illustrate the present invention.
- 28 mg (0.087 mmol) of (4S,5S)-3-t-butoxycarbonyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid, in solution in 1.5 cm 3 of anhydrous toluene, are put, under an argon atmosphere, into a 10 cm3 round-bottomed flask equipped with a magnetic stirrer system. 18 mg (0.087 mmol) of distilled dicyclohexylcarbodiimide are then added. The mixture is left to react for 5 minutes at a temperature in the region of 20° C. and then, in a single step, a mixture of 3.5 mg (0.029 mmol) of 4-(N,N-dimethylamino)pyridine and 26 mg (0.029 mmol) of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1,13α-dihydroxy-9-oxo-7β,10β-bis(2,2,2-trichloroethoxycarbonyloxy)-11-taxene is added. The mixture is left to react for 5 minutes at a temperature in the region of 20° C. and then is heated for 16 hours at 72° C. After cooling to a temperature in the region of 20° C., 40 cm3 of ethyl acetate are added. The organic phase is washed with 5 cm3 of distilled water, 2 times 5 cm3 of a saturated aqueous sodium hydrogencarbonate solution and then with 5 cm3 of a saturated aqueous sodium chloride solution and finally dried over anhydrous sodium sulphate. After filtration and evaporation of the solvents under reduced pressure, a residue (solid) is obtained which is purified by preparative silica thin layer chromatography, eluting with an ether/hexane/dichloromethane (5/20/75 by volume) mixture. There are thus obtained, with a yield of 86%, 30 mg (0.025 mmol) of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-9-oxo-7β,10β-bis(2,2,2-trichloroethoxycarbonyl)oxy-11-taxen-13α-yl (4S,5R)-3-t-butoxycarbonyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylate, the characteristics of which are the following:
- infrared spectrum (film): main characteristic absorption bands at 3450, 2970, 2910, 1760, 1720, 1700, 1600, 1580, 1450, 1375, 1360, 1245, 1170, 1135, 1100, 1080, 1060, 1020, 995, 975, 960, 900, 820, 765 and 720 cm −1
- proton nuclear magnetic resonance spectrum (300 MHz, CDCl 3, chemical shifts in ppm, coupling constants J in Hz): 1.18 (s, 12H), 1.27 (s, 3H), 1.6-2.0 (m, 1H), 1.76 (s, 3H), 1.81 (s, 3H), 1.83 (s, 3H), 1.95 (s, 3H), 2.05 (s, 3H), 2.20 (d, J=9, 2H), 2.55-2.65 (m, 1H), 3.90 (d, J=7, 1H), 4.20 (ABq, JAB=8.5, δA−δB=47.2, 2H), 4.47 (d, J=6.4, 1H), 4.75 (ABq, JAB=12, δA−δB=92.2, 2H), 4.78 (s, 2H), 4.91 (d, J=12, 1H), 5.12 (broad s, 1H), 5.58 (dd, J=7.1 and 10.6, 1H), 5.67 (d, J=7, 1H), 6.25 (s, 1H), 6.28 (t, J=9, 1H), 7.2-7.4 (m, 5H, aromatic protons), 7.47-7.52 (m, 2H, aromatic protons), 7.61-7.66 (m, 1H, aromatic proton), 8.03-8.05 (m, 2H, aromatic protons)
- mass spectrum (FAB(+)−NBA matrix): molecular ion (large): M + (1198).
- (4S,5S)-3-t-Butoxycarbonyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid can be prepared in the following way:
- 40 mg (0.12 mmol) of (4S,5S)-3-t-butoxycarbonyl-2,2-dimethyl-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine, 5 cm 3 of methanol, 2 cm3 of distilled water and 50 mg (0.36 mmol) of solid potassium carbonate are introduced successively into a 25 cm3 round-bottomed flask equipped with a magnetic stirrer system. The reaction mixture is stirred for 40 hours at a temperature in the region of 20° C. and then the methanol is evaporated under reduced pressure. 13 cm3 of water are added and the aqueous phase obtained is then washed 3 times with 20 cm3 of ethyl ether. The basic aqueous phase is cooled to 0° C. and is then acidified, in the presence of 20 cm3 of dichloromethane and with vigorous stirring, by addition of a 2M aqueous hydrochloric acid solution. The organic phase is separated by settling and the aqueous phase is then extracted 6 times with 30 cm3 of dichloromethane. The combined organic phases are washed 3 times with 5 cm3 of distilled water, then once with 5 cm3 of a saturated aqueous sodium chloride solution and then finally dried over anhydrous magnesium sulphate. After filtration and concentration to dryness under reduced pressure, there are obtained, with a yield of 99%, 38 mg (0.12 mmol) of (4S,5S)-3-t-butoxy-carbonyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid, the characteristics of which are the following:
- infrared spectrum (film): main characteristic absorption bands at 3650-2200, 2970, 2920, 1760, 1740, 1700, 1470, 1450, 1370, 1250, 1215, 1165, 1135, 1110, 1065, 875 and 690 cm −1
- proton nuclear magnetic resonance spectrum (200 MHz, CDCl 3, chemical shifts in ppm, coupling constants J in Hz): 1.20 (maj) and 1.43 (min) (2 broad s, 9H), 1.64 (s, 3H), 1.94 (s, 3H), 3.0 (very broad s, 1H), 4.97 (distorted d, J=7, 1H), 5-5.25 (m, 1H), 7.2-7.4 (m, 5H, aromatic protons)
- mass spectrum (C.I., NH 3+isobutane): 339 (MH+), 322 (MH+—OH), 283, 266, 222, 206, 158, 124, 110.
- (4S,5S)-3-t-Butoxycarbonyl-2,2-dimethyl-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine can be prepared in the following way:
- 147.5 mg (0.50 mmol) of methyl (2S,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate and 2.5 cm 3 of anhydrous toluene are introduced, under an argon atmosphere, into a 10 cm3 round-bottomed flask equipped with a magnetic stirrer system. 10 grains of 4 Å molecular sieve, 188.5 μl (144.2 mg, 2.0 mmol) of 2-methoxypropene and 12.5 mg (0.05 mmol) of pyridinium p-toluenesulphonate are then added to the suspension obtained. The mixture is allowed to react for 1 hour at a temperature in the region of 20° C. and is then heated to 120° C. and allowed to react at this temperature for 2 hours. The resulting dark-brown reaction mixture is cooled to a temperature in the region of 20° C. 60 cm3 of dichloromethane are added. The organic phase is washed with 5 cm3 of a saturated aqueous sodium hydrogen-carbonate solution, 3 times with 5 cm3 of water and then once with 5 cm3 of a saturated aqueous sodium chloride solution. The organic phase is dried over anhydrous sodium sulphate. After filtration and concentration to dryness under reduced pressure, a residue is obtained which is chromatographed on a column of silica gel, eluting with an ethyl ether/hexane (15/85 by volume) mixture. There are obtained, with a yield of 36%, 60 mg (0.18 mmol) of (4S,5S)-3-t-butoxycarbonyl-2,2-dimethyl-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine, the characteristics of which are the following:
- infrared spectrum (film): main characteristic absorption bands at 3060, 3025, 2975, 2920, 1775, 1740, 1700, 1490, 1480, 1450, 1440, 1365, 1250, 1210, 1165, 1110, 1070, 1050, 1030, 890, 760, 720 and 695 cm −1
- proton nuclear magnetic resonance spectrum (200 MHz, CDCl 3, chemical shifts in ppm, coupling constants J in Hz): 1.20 (maj) and 1.43 (min) (2 broad s, 9H), 1.63 (s, 3H), 1.90 (min) and 1.95 (maj) (2 broad s, 3H), 3.32 (s, 3H), 4.95-5.20 (m, 1H), 4.97 (distorted d, J=7, 1H), 7.15-7.40 (m, 5H, aromatic protons)
- mass spectrum (C.I., NH 3+isobutane): 353 (M+NH4 +), 336 (MH+), 320 (M+—CH3), 297, 280, 239, 236, 222, 220.
- Methyl (2S,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate can be prepared in the following way:
- A 4N aqueous sodium hydroxide solution is added, over 5 minutes, to a suspension of 6.5 g of α-methylbenzylamine (2S,3R)-phenylglycidate in 20 cm 3 of toluene and 10 cm3 of water. After stirring for 2 hours at a temperature in the region of 20° C., the separated aqueous phase is extracted with 2 times 7 cm3 of toluene. The aqueous phase is introduced into an autoclave. After having added 97.5 cm3 of a 32% (w/v) aqueous ammonia solution and 1.22 g of ammonium chloride, the autoclave is closed and then heated, with stirring, for 6 hours at 60° C. (autogenous pressure of 3 bar). After cooling to a temperature in the region of 20° C., 6 cm3 of a 4N aqueous sodium hydroxide solution are added. The mixture is stirred for 30 minutes, the ammonia is removed under reduced pressure and then the mixture is concentrated to dryness under reduced pressure (45 mm of mercury, 6 kPa) at 45° C. The residue obtained is taken up in 75 cm3 of methanol. A methanolic sulphuric acid solution consisting of 4.83 g of concentrated sulphuric acid in 20 cm3 of methanol is added over 35 minutes at 20° C. to the suspension obtained. The reaction mixture is heated at 50° C. for 3 hours 30 minutes. After cooling to 0° C., a solution of 27 g of sodium carbonate in 20 cm3 of water is added. After evolution of carbon dioxide has ceased, the reaction mixture is cooled to 23° C. over 30 minutes. A solution of 6.1 g of di-t-butyl dicarbonate in 7 cm3 of methanol is then added over 30 minutes. The mixture is stirred for 4 hours and then, after evaporation of 50 cm3 of methanol, 60 cm3 of water are added and then all the methanol is evaporated. The product which precipitates is separated by filtration, washed with 2 times 25 cm3 of water and dried to constant weight. There are thus obtained, with a yield of 30%, 2 g of methyl (2S,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate, the characteristics of which are the following:
- melting point: 135.5-136° C.
- optical rotation: [α] D 25=+29.6° (c=0.5, chloroform)
- infrared spectrum (film): main characteristic absorption bands at 3380, 3350, 3000, 2970, 2930, 1720, 1690, 1510, 1435, 1385, 1360, 1310, 1285, 1230, 1205, 1170, 1105, 1005, 860, 770, 750, 730 and 690 cm −1
- proton nuclear magnetic resonance spectrum (200 MHz, CDCl 3, chemical shifts in ppm, coupling constants J in Hz): 1.43 (s, 9H), 2.84 (d, J=7, 1H), 3.71 (s, 3H), 4.60 (dd, J=3.5 and 7, 1H), 5.10 (distorted d, J=8, 1H), 7.20-7.37 (m, 5H, aromatic protons)
- proton nuclear magnetic resonance spectrum (360 MHz, d 6-DMSO, 298° K., chemical shifts in ppm, coupling constants J in Hz): 1.31 (broad s, 9H), 3.55 (s, 3H), 4.14 (d, J=7.7, 1H), 4.71 (dd, 1H), 5.65 (broad s, 1H), 7.18 (d, J=7, 1H), 7.15-7.3 (m, 5H).
- 9 mg (0.028 mmol) of (4S,5S)-3-benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid, in solution in 0.46 cm 3 of anhydrous toluene, are put into a 5 cm3 single-necked, round-bottomed flask equipped with a magnetic stirrer system. 5.7 mg (0.028 mmol) of dicyclohexylcarbodiimide are then added. The reaction mixture, which has become cloudy, is allowed to react for 5 minutes at a temperature in the region of 20° C. and then a mixture of 6.4 mg (0.009 mmol) of 4,10β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1,13α-dihydroxy-9-oxo-7β-triethylsilyloxy-11-taxene and 1.1 mg (0.009 mmol) of 4-(N,N-dimethylamino)pyridine is added. The reaction mixture is allowed to react for 5 minutes at a temperature in the region of 20° C. and is then heated for 16 hours at 72° C.
- After cooling to a temperature in the region of 20° C., the reaction mixture is diluted by addition of 40 cm 3 of ethyl acetate. The organic phase is washed with 2 times 5 cm3 of a saturated aqueous sodium bicarbonate solution, 3 times 5 cm3 of water, then once with 5 cm3 of a saturated aqueous sodium chloride solution and is finally dried over anhydrous sodium sulphate. After filtration and removal of the solvents under reduced pressure, the residue obtained (21 mg) is purified by silica thin layer chromatography, eluting with an ethyl ether/dichloromethane (8/92 by volume) mixture over two passes. There are thus obtained, with a yield of 91%, 8.4 mg (0.008 mmol) of 4,10β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-9-oxo-7β-triethylsilyloxy-11-taxen-13α-yl (4S,5R)-3-benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylate, the characteristics of which are the following:
- infrared spectrum (film): main characteristic absorption bands at 3400, 2930, 2850, 1730, 1720, 1630, 1590, 1570, 1440, 1360, 1340, 1230, 1195, 1065, 1015, 1005, 980 and 810 cm −1
- proton nuclear magnetic resonance spectrum (400 MHz, CDCl 3, chemical shifts in ppm, coupling constants J in Hz): 0.54-0.61 (m, 6H), 0.92 (t, J=8, 9H), 1.20 (s, 3H), 1.22 (s, 3H), 1.65 (s, 3H), 1.86 (s, 3H), 1.93 (broad s, 3H), 2.00 (s, 3H), 2.08 (s, 3H), 2.19 (s, 3H), 1.82-2.15 (m, 3H), 2.46-2.54 (m, 1H), 3.77 (d, J=7.2, 1H), 4.16 (ABq, JAB=8.4, δA−δB=59.4, 2H), 4.46 (dd, J=6.6 and 10.5, 1H), 4.56 (d, J=6.8, 1H), 4.88 (d, J=8, 1H), 5.27 (d, J=6, 1H), 5.64 (d, J=7.2, 1H), 6.24 (t, J=9, 1H), 6.45 (s, 2H), 6.94 (broad s, 2H, aromatic protons), 7.11-7.26 (m, 8H, aromatic protons), 7.44-7.48 (m, 2H, aromatic protons), 7.59-7.61 (m, 1H, aromatic proton), 8.00-8.02 (m, 2H, aromatic protons)
- 13C magnetic resonance spectrum (100 MHz, CDCl3): 5.20, 6.69, 9.99, 14.26, 20.82, 21.07, 21.62, 26.42, 35.27, 37.04, 43.18, 46.69, 58.28, 65.97, 71.68, 72.06, 74.79, 74.85, 76.32, 78.93, 80.74, 84.09, 93.43, 102.65, 126.11, 126.86, 127.83, 128.02, 128.50, 128.69, 129.14, 129.43, 130.00, 133.67, 133.82, 138.81, 139.90, 166.93, 169.13, 169.85, 201.60
- mass spectrum (FAB(+)−NBA matrix+KCl): 1046, 1008 (MH +), 948, 930.
- (4S,5S)-3-Benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid can be prepared in the following way:
- 12.5 mg (0.04 mmol) of (4S,5R)-5-vinyl-3-benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine, in solution in 80 μl of acetonitrile, are put into a 2 cm 3 single-necked, round-bottomed flask equipped with a magnetic stirrer system. 80 μl of carbon tetrachloride, 120 μl of water and 22 mg (0.26 mmol) of pure sodium bicarbonate are then successively added. 47 mg (0.22 mmol) of sodium periodate are then added in small portions with vigorous stirring. The mixture is allowed to react for 5 minutes at a temperature in the region of 20° C. and then 2.4 mg of ruthenium trichloride are added in a single step. The resulting black heterogeneous mixture is stirred vigorously at 20° C. for 72 hours.
- The reaction mixture is diluted in 10 cm 3 of water. The basic organic phase obtained is washed with 3 times 10 cm3 of ether. The basic aqueous phase is cooled to 0° C. and is then acidified, with vigorous stirring and in the presence of 20 cm3 of dichloromethane, with a 2M aqueous hydrochloric acid solution to pH=1. After settling, the acidic aqueous phase is extracted with 6 times 15 cm3 of dichloromethane. The combined organic phases are washed 3 times with 5 cm3 of water and then once with 5 cm3 of a saturated aqueous sodium chloride solution. After drying over anhydrous sodium sulphate and filtration, the organic phase is concentrated to dryness under reduced pressure. There are thus obtained, with a yield of 77%, 10.0 mg (0.031 mmol) of (4S,5S)-3-benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid, the characteristics of which are the following:
- infrared spectrum (film): main characteristic absorption bands at 3700-2300, 2970, 2940, 2930, 2900, 2825, 1740, 1600, 1590, 1570, 1420-1400, 1370, 1360, 1190, 1180, 1150, 1120, 1090 and 855 cm −1
- proton nuclear magnetic resonance spectrum: (200 MHz, CDCl 3, chemical shifts in ppm): 1.81 (s, 3H), 2.11 (s, 3H), 4.90-5.06 (m, 2H), 6.78-6.93 (m, 4H, aromatic protons), 7.07-7.30 (m, 6H, aromatic protons).
- (4S,5R)-5-Vinyl-3-benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine can be prepared in the following way:
- 32 mg (0.12 mmol) of (1S,2R)-1-phenyl-1-benzoylamino-2-hydroxy-3-butene, in suspension in 0.64 cm 3 of anhydrous toluene, are put, under an argon atmosphere, in a 10 cm3 single-necked, round-bottomed flask equipped with a magnetic stirrer system and a reflux condenser. 226 μl (173 mg, 2.4 mmol) of 2-methoxypropene, 6.0 mg (0.024 mmol) of pyridinium p-toluenesulphonate and 8 grains of 4 Å molecular sieve are then added. The resulting reaction mixture is allowed to react at a temperature in the region of 15° C. for 2.5 hours and is then heated at 100° C. for 2 hours. After cooling to a temperature in the region of 15° C., the reaction mixture is diluted in 40 cm3 of dichloromethane. The organic phase is washed once with 5 cm3 of a saturated sodium bicarbonate solution, 3 times with 5 cm3 of water and once with a saturated aqueous sodium chloride solution and is then dried over anhydrous sodium sulphate. After filtration and concentration to dryness under reduced pressure, the residue obtained is purified by chromatography on silica gel, eluting a first time with an ethyl ether/dichloromethane (2/98 by volume) mixture and then a second time with an ethyl acetate/hexane (10/90 by volume) mixture. There are thus obtained, with a yield of 38%, 14 mg (0.0456 mmol) of (4S,5R)-5-vinyl-3-benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine, the characteristics of which are the following:
- infrared spectrum (film): main characteristic absorption bands at 3050, 3010, 2980, 2920, 1635, 1595, 1570, 1490, 1385, 1370, 1355, 1245, 1215, 1145, 1065, 1030, 1020, 935, 850 and 690 cm −1
- proton nuclear magnetic resonance spectrum (400 MHz, CDCl 3, chemical shifts in ppm, coupling constants J in Hz): 1.78 (s, 3H), 2.01 (s, 3H), 4.59 (d, J=6.4, 1H), 4.79 (pst, J=6.4, 1H), 4.97-5.10 (m, 2H), 5.21-5.26 (m, 1H), 6.78-6.94 (m, 4H, aromatic protons), 7.04-7.30 (m, 6H, aromatic protons).
- 23 mg (0.058 mmol) of (2R,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylic acid in 1 cm 3 of anhydrous toluene are introduced, under an argon atmosphere, into a 5 cm3 single-necked, round-bottomed flask equipped with a magnetic stirrer system and then 11.9 mg (0.058 mmol) of dicyclohexylcarbodiimide are added. The mixture is allowed to react for 5 minutes at a temperature in the region of 25° C. and then a mixture of 2.3 mg (0.019 mmol) of 4-(N,N-dimethylamino)pyridine and 17 mg (0.019 mmol) of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1,13α-dihydroxy-9-oxo-7β,10β-bis(2,2,2-trichloroethoxycarbonyloxy)-11-taxene is added. The mixture is allowed to react for 5 minutes at 25° C. and is then heated for 24 hours at 74° C. After evaporation of the toluene under reduced pressure, the residue obtained (74 mg) is purified by silica gel thin layer chromatography, eluting with an ethyl ether/dichloromethane (5/95 by volume) mixture. There are thus obtained 23.4 mg (0.012 mmol) of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-9-oxo-7β,10β-bis(2,2,2-trichloroethoxycarbonyl)oxy-11-taxen-13α-yl (2R,4S,5R)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylate contaminated with 15% of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-9-oxo-7β,10β-bis(2,2,2-trichloroethoxycarbonyl)oxy-11-taxen-13α-yl (2R,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylate.
- 4-Acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-9-oxo-7β,10β-bis(2,2,2-trichloroethoxycarbonyl)oxy-11-taxen-13α-yl (2R,4S,5R)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylate has the following characteristics:
- melting point: 164-167° C.
- infrared spectrum (film): main characteristic absorption bands at 3500, 2950, 2900, 1760, 1730, 1720, 1700, 1605, 1580, 1505, 1380, 1375, 1360, 1240, 1140, 1060, 815, 760 and 710 cm −1
- proton nuclear magnetic resonance spectrum (500 MHz, CDCl 3, chemical shifts in ppm, coupling constants J in Hz): 1.05 (s, 9H), 1.16 (s, 3H), 1.24 (s, 3H), 1.64 (s, 3H), 1.80 (s, 3H), 1.85 (broad s, 3H), 1.98-2.05 (m, 1H), 2.07-2.14 (m, 1H), 2.18-2.26 (m, 1H), 2.53-2.64 (m, 1H), 3.81 (d, J=7.0, 1H), 3.82 (s, 3H), 4.18 (ABq, JAB=8.5, δA−δB=80.7, 2H), 4.58 (s, 1H), 4.74 (ABq, JAB=11.8, δA−δB=150.6, 2H), 4.77 (ABq, JAB=11.8, δA−δB=7.7, 2H), 4.88 (distorted d, J=9.3, 1H), 5.41 (broad s, 1H), 5.50 (dd, J=7.2 and 10.7, 1H), 5.64 (d, J=7.0, 1H), 6.10 (t, J=8.8, 1H), 6.14 (s, 1H), 6.40 (broad s, 1B), 6.93 (d, J=8.8, 2H, aromatic protons), 7.26-7.44 (m, 7H, aromatic protons), 7.48-7.52 (m, 2H, aromatic protons), 7.62-7.65 (m, 1H, aromatic proton), 8.01-8.03 (m, 2H, aromatic protons).
- 13 mg (0.01 mmol) of the ester obtained above (mixture of the 2 epimers), in solution in 0.75 cm 3 of methanol, are introduced into a 5 cm3 single-necked flask equipped with a magnetic stirrer system and then 0.75 cm3 of glacial acetic acid is added. The mixture is heated at 65° C. for 5 minutes and then 65 mg of zinc/copper couple (prepared from 20 g of zinc and 3 g of copper sulphate monohydrate) are added. The black heterogeneous mixture is stirred at 65° C. for 30 minutes. After cooling to a temperature in the region of 25° C., the reaction mixture is diluted in 30 cm3 of dichloromethane. Filtration is carried out through Celite and then the solids are washed 3 times with 10 cm3 of dichloromethane. The solvents are removed under reduced pressure. The residue obtained is purified by silica gel thin layer chromatography, eluting with a methanol/dichloromethane (5/95 by volume) mixture. There are thus obtained, with a yield of 60%, 5.6 mg (0.006 mmol) of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-9-oxo-1,7β,10β-trihydroxy-11-taxen-13α-yl (2R,4S,5R)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylate contaminated with 15-20% of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-9-oxo-1,7β,10β-trihydroxy-11-taxen-13α-yl (2R,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylate.
- 4-Acetoxy-2α-benzoyloxy-5β,20-epoxy-9-oxo-1,7β,10β-trihydroxy-11-taxen-13α-yl (2R,4S,5R)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylate has the following characteristics:
- infrared spectrum (film): characteristic absorption bands at 3430, 2960, 2880, 2840, 1730, 1720, 1700, 1685, 1605, 1580, 1505, 1440, 1380, 1360, 1340, 1265, 1240, 1170, 1130, 1060, 1015, 975, 905, 720 and 695 cm −1
- proton nuclear magnetic resonance spectrum (400 MHz, CDCl 3, chemical shifts in ppm, coupling constants J in Hz): 1.05 (s, 9H), 1.09 (s, 3H), 1.20 (s, 3H), 1.57 (s, 3H), 1.70 (s, 3H), 1.73-1.90 (m, 1H), 1.85 (broad s, 3H), 2.02-2.19 (m, 2H), 2.47-2.60 (m, 1H), 3.81 (d, J=7, 1H), 3.82 (s, 3H), 4.15 (d, J=1.5, 1H), 4.18 (ABq, JAB=8.5, δA−δB=55.6, 2H), 4.56 (d, J=5.0, 1H), 4.87 (dis. dd, J=8, 1H), 5.10 (d, J=1.5, 1H), 5.42 (broad s, 1H), 5.62 (d, J=4, 1H), 6.13 (t, J=8, 1H), 6.39 (broad s, 1H), 6.92 (m, 2H, aromatic protons), 7.30-7.44 (m, 7H, aromatic protons), 7.47-7.51 (m, 2H, aromatic protons), 7.59-7.64 (m, 1H, aromatic proton), 8.01-8.05 (m, 2H, aromatic protons)
- mass spectrum (FAB(+)−NBA matrix+KCl): 1276 (M +)
- elemental analysis (C 57H61O19NCl6):
C % H % N % calculated 53.62 4.81 1.10 found 53.22 4.82 1.16 - 4.4 mg (0.0047 mmol) of the product obtained above are introduced into a 5 cm 3 single-necked flask equipped with a magnetic stirrer. The mixture is cooled to 0° C. and then 64 μl of an ethyl acetate solution containing 0.28 μl of 33% hydrochloric acid are added. The resulting homogeneous reaction mixture is allowed to react for 5 minutes at 0° C. and then for 5 hours at a temperature in the region of 25° C. The reaction mixture is diluted in 20 cm3 of ethyl acetate and then the organic phase is treated with 5 cm3 of a saturated aqueous sodium bicarbonate solution. The organic phase, separated by settling, is washed with 3 times 5 cm3 of water and once with 5 cm3 of a saturated aqueous sodium chloride solution and is then dried over anhydrous sodium sulphate. After filtration and concentration to dryness under reduced pressure, the residue obtained is purified by silica gel thin layer chromatography, eluting with a methanol/dichloromethane (5/95 by volume) mixture. There are thus obtained, with a yield of 78%, 3.0 mg (0.0037 mmol) of pure 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-9-oxo-1,7β,10β-trihydroxy-11-taxen-13α-yl (2R,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate (or Taxotere) which contains no trace of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-9-oxo-1,7β,10β-trihydroxy-11-taxen-13α-yl (2S,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate.
- There is recovered 0.8 mg (0.0009 mmol) of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-9-oxo-1,7β,10β-trihydroxy-11-taxen-13α-yl (2R,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylate which is not deprotected under the conditions used.
- The Taxotere thus obtained has the following characteristics:
- infrared spectrum (film): main characteristic absorption bands at 3450, 3100, 3050, 2950, 2920, 2890, 2850, 1730, 1710, 1600, 1580, 1490, 1450, 1390, 1370, 1315, 1270, 1245, 1160, 1105, 1095, 1070, 1020, 980, 910, 730 and 710 cm −1
- proton nuclear magnetic resonance spectrum (300 MHz, CDCl 3, chemical shifts in ppm, coupling constants J in Hz):
- 1.13 (s, 3H), 1.24 (s, 3H), 1.34 (s, 9H), 1.76 (s, 3H), 1.85 (s, 3H), 1.74-1.85 (m, 1H), 2.26-2.29 (m, 2H), 2.37 (s, 3H), 2.54-2.66 (m, 1H), 3.31 (distorted d, J=4.4, 1H), 3.92 (d, J=7, 1H), 4.18-4.30 (m, 1H), 4.18 (s, 1H), 4.25 (AB q, JAB=8.3, δA−δB35.3, 2H), 4.62 (broad s, 1H), 4.94 (d, J=8.5, 1H), 5.20 (s, 1H), 5.26 (broad distorted s, 1H), 5.41 (distorted d, J=9.4, 1H), 5.68 (d, J=7, 1H), 6.21 (t, J=8.0 and 8.8, 1H), 7.31-7.40 (m, 5H, aromatic protons), 7.47-7.52 (m, 2H, aromatic protons), 7.59-7.64 (m, 1H, aromatic proton), 8.09-8.12 (m, 2H, aromatic protons).
- (2R,4S,5S)-3-t-Butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylic acid can be prepared in the following way:
- 33 mg (0.08 mmol) of (2R,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine, in suspension in 15 cm 3 of methanol, are put, under an argon atmosphere, into a 50 cm3 round-bottomed flask equipped with a magnetic stirrer system. 5 cm3 of water and 33 mg (0.24 mmol) of potassium carbonate are then added. The mixture is allowed to react for 96 hours at a temperature in the region of 25° C. The reaction mixture becomes homogeneous. The methanol is removed under reduced pressure. The basic aqueous phase is diluted in 10 cm3 of water and then extracted with 3 times 15 cm3 of ether. The aqueous phase is cooled to 0° C. and is then acidified, with vigorous stirring in the presence of 20 cm3 of dichloromethane, with a 4M aqueous hydrochloric acid solution to-a pH of less than 1. The acidic aqueous phase is extracted 8 times with 20 cm3 dichloromethane. The combined organic phases are washed with 3 times 5 cm3 of water and then once with 5 cm3 of a saturated aqueous sodium chloride solution. The organic phases are dried over anhydrous sodium sulphate. After filtration and concentration to dryness under reduced pressure, there are obtained, with a yield of 94%, 30.0 mg (0.075 mmol) of (2R,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylic acid, the characteristics of which are the following:
- melting point: 148.5-150.5° C.
- optical rotation: [α] D 25=+46.4° (c=1.0, chloroform)
- infrared spectrum (film): main characteristic absorption bands at 3700-2300, 2950, 2900, 2820, 1755, 1700, 1605, 1580, 1505, 1385, 1360, 1300, 1285, 1240, 1215, 1165, 1130, 1075, 1065, 1020, 930, 900, 850, 820 and 685 cm −1
- proton nuclear magnetic resonance spectrum in the form of 2 rotamers (200 MHz, CDCl 3), chemical shifts in ppm, coupling constants J in Hz): 1.11 (s, 9H), 3.82 (s, 3H), 4.2 (very broad s, 1H), 4.99 (d, J=6.4, 1H), 5.18 (majo distorted d, J=6.4) and 5.36 (mino, broad s) (1H), 6.46 (mino) and 6.66 (majo) (s, 2H), 6.94 (d, J=8.6, 2H, aromatic protons), 7.20-7.46 (m, 7H, aromatic protons).
- mass spectrum (C.I., NH 3+isobutane): 417 (MH++NH3), 400 (MH+), 361, 344, 300, 264, 225, 192, 177, 137.
- (2R,4S,5S)-3-t-Butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine can be prepared according to one of the following methods:
- 1) 10 mg (0.034 mmol) of methyl (2S,3S)-3-t-butoxycarbonyl-3-phenyl-2-hydroxypropionate, in suspension in 0.5 cm 3 of anhydrous toluene, are put, under an argon atmosphere, into a 2 cm3 single-necked, round-bottomed flask equipped with a magnetic stirrer system. 1 mg (0.004 mmol) of pyridinium p-toluenesulphonate is then added. The resulting reaction mixture is heated to 115° C. After 5 minutes at this temperature, 13 μl (13.9 mg, 0.076 mmol) of p-methoxybenzaldehyde dimethyl acetal are added. The reaction mixture, which has become homogeneous, is heated at reflux of the solvent for 5 minutes. After cooling to a temperature in the region of 20° C., the reaction mixture is diluted in 30 cm3 of dichloromethane. The organic phase is treated once with 5 cm3 of a saturated aqueous sodium bicarbonate solution and then washed with 2 times 5 cm3 of water and once with 5 cm3 of a saturated aqueous sodium chloride solution. After drying over anhydrous sodium sulphate, filtration and concentration to dryness under reduced pressure, the residue is purified by silica gel thin layer chromatography, eluting with an ethyl ether/hexane (6/4 by volume) mixture. There are thus obtained 13.9 mg (0.0336 mmol) of a mixture of (2R,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine and (2S,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine in the ratio 40/60. The overall yield is 99%.
- These esters can be separated by chromatography on a column of silica gel, eluting with an ethyl ether/hexane (2/8 by volume) mixture.
- (2R,4S,5S)-3-t-Butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine has the following characteristics:
- melting point: 208-208.5° C.
- optical rotation [α] D 25=+53° (c=1.1, chloroform)
- infrared spectrum (film): 2950, 1725, 1680, 1600, 1575, 1500, 1380, 1350, 1280, 1260, 1240, 1200, 1160, 1120, 1065, 1050, 1030 and 1010 cm −1
- proton nuclear magnetic resonance spectrum in the form of 2 rotamers (200 MHz, CDCl3, chemical shifts in ppm, coupling constants J in Hz): 1.12 (s, 9H), 3.32 (s, 3H), 3.82 (s, 3H), 5.00 (d, J=6.5, 1H), 5.16 (majo, distorted d, J=5.6) and 5.34 (mino, broad s, 1H), 6.48 (mino) and 6.68 (majo) (2s, 1H), 6.93 (d, J=8.4, 2H, aromatic protons), 7.20-7.50 (m, 7H, aromatic protons)
- mass spectrum (D/CI, NH 3+isobutane): 414 (MH+), 356, 314, 312, 250, 222, 206, 179, 177, 162, 151, 134, 119.
- (2S,4S,5S)-3-t-Butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine has the following characteristics:
- infrared spectrum (film): main characteristic absorption bands at 2950, 2900, 1760, 1730, 1695, 1600, 1580, 1505, 1450, 1430, 1380, 1360, 1335, 1290, 1240, 1210, 1160, 1150, 1080, 1030, 1020, 920, 801 and 680 cm −1
- proton nuclear magnetic resonance spectrum (200 MHz, CDCl3, chemical shifts in ppm, coupling constants J in Hz): 1.26 (s, 9H), 3.37 (s, 3H), 3.82 (s, 3H), 5.01 (d, J=7.1, 1H), 5.27 (d, J=7.1, 1H), 6.05 (s, 1H), 6.91 (d, J=8.4, 2H, aromatic protons), 7.26-7.56 (m, 5H, aromatic protons), 7.49 (d, J=8.4, 2H, aromatic protons)
- mass spectrum (D/CI, NH 3+isobutane): 414 (MH+), 356, 339, 314, 312, 296, 250, 224, 222, 206, 177, 162, 151, 135, 121.
- 2) 5.0 mg (0.017 mmol) of methyl (2S,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate, in suspension in 0.25 cm 3 of anhydrous toluene, are put, under an argon atmosphere, in a 2 cm3 round-bottomed flask equipped with a magnetic stirrer system. 10.0 μl (10.7 mg, 0.059 mmol) of p-methoxybenzaldehyde dimethyl acetal are then added. The resulting reaction mixture is heated to 95° C. and then 1 mg of pyridinium-polymer p-toluenesulphonate is added. Heating is continued for 24 hours at 95° C. After cooling to a temperature in the region of 20° C., the reaction mixture is diluted in 30 cm3 of dichloromethane. The organic phase is treated once with 5 cm3 of a saturated aqueous sodium bicarbonate solution, then washed with 3 times with 5 cm3 of water and once with 5 cm3 of a saturated aqueous sodium chloride solution. After drying over anhydrous sodium sulphate, filtration and concentration to dryness, there are obtained, after purification by silica gel thin layer chromatography, eluting with an ethyl ether/hexane (1/1 by volume, 2 passes) mixture, with a yield of 93%, 6.5 mg (0.016 mmol) of a mixture of (2R,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine and (2S,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine in the ratio 30/70.
- 3) 10.0 mg (0.034 mmol) of methyl (2S,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate, in suspension in 0.5 cm 3 of anhydrous toluene, are put, under an argon atmosphere, in a 2 cm3 single-necked, round-bottomed flask equipped with a magnetic stirrer system. 13.0 μl (13.9 mg, 0.076 mmol) of p-methoxybenzaldehyde dimethyl acetal are then added. The resulting reaction mixture is heated at 74° C. for 5 minutes and then 2.5 mg of p-toluenesulphonic acid monohydrate are added. Heating is continued at 74° C. for 17 hours. After cooling, the reaction mixture is diluted in 30 cm3 dichloromethane. The organic phase is treated once with 5 cm3 of a saturated aqueous sodium bicarbonate solution, then washed 2 times with 5 cm3 of water and once with 5 cm3 of a saturated aqueous sodium chloride solution. After drying over anhydrous sodium sulphate, filtration and concentration to dryness under reduced pressure, there are obtained, after purification by silica gel thin layer chromatography, eluting with an ethyl ether/hexane (1/1 by volume) mixture, with yield of 45%, 6.3 mg (0.015 mmol) of a mixture of (2R,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine and (2S,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine in the ratio 61/39.
- 4) 5.0 mg (0.017 mmol) of methyl (2S,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate, in suspension in 0.25 cm 3 of anhydrous toluene, are put, under an argon atmosphere, in a 2 cm3 single-necked, round-bottomed flask equipped with a magnetic stirrer system. 6.5 μl (6.95 mg, 0.038 mmol) of p-methoxybenzaldehyde dimethyl acetal are then added. The resulting reaction mixture is heated at 76° C. for 5 minutes and then 0.5 mg (0.002 mmol) of camphorsulphonic acid is added. Heating is continued at 76° C. After reacting for 4 hours, 4.0 μl (2.43 mg, 0.076 mmol) of methanol are added and the mixture is allowed to react for a further 44 hours at 76° C. After cooling, the reaction mixture is diluted in 30 cm3 of dichloromethane. The organic phase is treated once with 5 cm3 of a saturated aqueous sodium bicarbonate solution, then washed 2 times with 5 cm3 of water and once with 5 cm3 of a saturated aqueous sodium chloride solution. After drying over anhydrous sodium sulphate, filtration and concentration to dryness under reduced pressure, there are obtained, after purification by silica gel thin layer chromatography, eluting with an ethyl ether/hexane (3/2 by volume) mixture, with a yield of 53%, 3.7 mg (0.009 mmol) of a mixture of (2R,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine and (2S,4S,5S)-3-t-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-5-methoxycarbonyl-1,3-oxazolidine in the ratio 74/26.
Claims (16)
1. Process for the preparation of taxane derivatives of general formula:
in which
Ar represents an aryl radical,
R represents the phenyl radical or a radical R5—O— in which R5 represents
a straight or branched alkyl radical containing 1 to 8 carbon atoms, an alkenyl radical containing 2 to 8 carbon atoms, an alkynyl radical containing 3 to 8 carbon atoms, a cycloalkyl radical containing 3 to 6 carbon atoms, a cycloalkenyl radical containing 4 to 6 carbon atoms or a bicycloalkyl radical containing 7 to 11 carbon atoms, these radicals optionally being substituted by one or a number of substituents chosen from the halogen atoms and the hydroxyl radical, alkoxy radical containing 1 to 4 carbon atoms, dialkylamino radical, each alkyl part of which contains 1 to 4 carbon atoms, piperidino radical, morpholino radical, 1-piperazinyl radical (optionally substituted in the 4-position by an alkyl radical containing 1 to 4 carbon atoms or by a phenylalkyl radical, the alkyl part of which contains 1 to 4 carbon atoms), cycloalkyl radical containing 3 to 6 carbon atoms, cycloalkenyl radical containing 4 to 6 carbon atoms, phenyl cyano radical, carboxyl radical or alkoxycarbonyl radical, the alkyl part of which contains 1 to 4 carbon atoms,
or a phenyl radical optionally substituted by one or a number of atoms or radicals chosen from the halogen atoms and the alkyl radicals containing 1 to 4 carbon atoms or the alkoxy radicals containing 1 to 4 carbon atoms,
a saturated or unsaturated nitrogen-containing heterocyclyl radical containing 4 to 6 members and optionally substituted by one or a number of alkyl radicals containing 1 to 4 carbon atoms, it being understood that the cycloalkyl, cycloalkenyl or bicycloalkyl radicals may optionally be substituted by one or a number of alkyl radicals containing 1 to 4 carbon atoms,
R1 and R2, which are identical or different, represent a hydrogen atom or an alkyl, phenylalkyl, phenyl, alkoxyphenyl or dialkoxyphenyl radical or else Rl and R2 form, together with the carbon atom to which they are bonded, a ring having from 4 to 7 members,
R3 represents an acetyl radical or a protective group of the hydroxyl functional group and
R4 represents a protective group of the hydroxyl functional group, characterized in that protected baccatin III or protected 10-deacetylbaccatin III of general formula:
in which R3 and R4 are defined as above, is esterified by means of an acid of general formula:
in which Ar, R, R1 and R2 are defined as above, or of an activated derivative of this acid.
2. Process according to claim 1 , characterized in that the esterification is carried out by means of an acid of general formula:
in which Ar, R, R1 and R2 are defined as in claim 1 , the reaction being carried out in the presence of a condensation agent and of an activating agent in an organic solvent at a temperature between 0 and 90° C.
3. Process according to claim 2 , characterized in that the condensation agent is chosen from imides and reactive carbonates and the activating agent is chosen from aminopyridines.
4. Process according to claim 3 , characterized in that the condensation agent is chosen from dicyclohexylcarbodiimide and di-2-pyridyl ketone and the activating agent is chosen from 4-dimethylaminopyridine or 4-pyrrolidinopyridine.
5. Process according to claim 2 , characterized in that the solvent is chosen from ethers, ketones, esters, nitrites, aliphatic hydrocarbons, halogenated aliphatic hydrocarbons and aromatic hydrocarbons.
6. Process according to claim 5 , characterized in that the solvent is chosen from aromatic hydrocarbons.
7. Process according to claim 1 , characterized in that the esterification is carried out by means of an anhydride of general formula:
in which Ar, R, R1 and R2 are defined as in claim 1 , the reaction being carried out in the presence of an activating agent in an organic solvent at a temperature between 0 and 90° C.
8. Process according to claim 7 , characterized in that the activating agent is chosen from aminopyridines.
9. Process according to claim 8 , characterized in that the activating agent is chosen from 4-dimethylaminopyridine or 4-pyrrolidinopyridine.
10. Process according to claim 7 , characterized in that the solvent is chosen from ethers, ketones, esters, nitrites, aliphatic hydrocarbons, halogenated aliphatic hydrocarbons and aromatic hydrocarbons.
11. Process according to claim 1 , characterized in that the esterification is carried out by means of an activated acid of general formula:
in which Ar, R, R1 and R2 are defined as in claim 1 and X represents a halogen atom or an acyloxy or aroyloxy radical, optionally prepared in situ in the presence of a base, the reaction being carried out in an organic solvent at a temperature between 0 and 90° C.
12. Process according to claim 11 , characterized in that the base is chosen from nitrogenous organic bases.
13. Process according to claim 12 , characterized in that the nitrogenous organic base is chosen from aliphatic tertiary amines, pyridine and aminopyridines.
14. Process according to claim 11 , characterized in that the organic solvent is chosen from ethers, ketones, esters, nitrites, aliphatic hydrocarbons, halogenated aliphatic hydrocarbons and aromatic hydrocarbons.
15. Process according to claim 14 , characterized in that the solvent is chosen from aromatic hydrocarbons.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/179,027 US20030013889A1 (en) | 1992-10-30 | 2002-06-26 | Process for the preparation of taxane derivatives |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9213000A FR2697522B1 (en) | 1992-10-30 | 1992-10-30 | Process for the preparation of taxane derivatives. |
| FRFR9213000 | 1992-10-30 | ||
| US08/424,386 US5686623A (en) | 1992-10-30 | 1993-10-28 | Method for preparing taxane derivatives |
| US08/908,807 US6433180B1 (en) | 1992-10-30 | 1997-08-08 | Carboxylic acids for synthesis of taxane derivatives |
| US10/179,027 US20030013889A1 (en) | 1992-10-30 | 2002-06-26 | Process for the preparation of taxane derivatives |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/908,807 Division US6433180B1 (en) | 1992-10-30 | 1997-08-08 | Carboxylic acids for synthesis of taxane derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20030013889A1 true US20030013889A1 (en) | 2003-01-16 |
Family
ID=9435013
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/424,386 Expired - Fee Related US5686623A (en) | 1992-10-30 | 1993-10-28 | Method for preparing taxane derivatives |
| US08/908,807 Expired - Fee Related US6433180B1 (en) | 1992-10-30 | 1997-08-08 | Carboxylic acids for synthesis of taxane derivatives |
| US10/179,027 Abandoned US20030013889A1 (en) | 1992-10-30 | 2002-06-26 | Process for the preparation of taxane derivatives |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/424,386 Expired - Fee Related US5686623A (en) | 1992-10-30 | 1993-10-28 | Method for preparing taxane derivatives |
| US08/908,807 Expired - Fee Related US6433180B1 (en) | 1992-10-30 | 1997-08-08 | Carboxylic acids for synthesis of taxane derivatives |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US5686623A (en) |
| EP (1) | EP0666857B1 (en) |
| JP (1) | JP3030088B2 (en) |
| KR (1) | KR100255460B1 (en) |
| AT (1) | ATE180258T1 (en) |
| AU (1) | AU679947B2 (en) |
| CA (1) | CA2148103C (en) |
| CZ (1) | CZ287805B6 (en) |
| DE (1) | DE69325031T2 (en) |
| DK (1) | DK0666857T3 (en) |
| ES (1) | ES2133418T3 (en) |
| FI (1) | FI109798B (en) |
| FR (1) | FR2697522B1 (en) |
| GR (1) | GR3030268T3 (en) |
| HU (1) | HUT73780A (en) |
| MX (1) | MX9306606A (en) |
| NO (2) | NO304114B1 (en) |
| NZ (1) | NZ257578A (en) |
| PL (1) | PL177746B1 (en) |
| RU (2) | RU2118958C1 (en) |
| SK (1) | SK281045B6 (en) |
| TW (1) | TW427988B (en) |
| WO (1) | WO1994010169A1 (en) |
| ZA (1) | ZA938012B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9307777A (en) | 1992-12-15 | 1994-07-29 | Upjohn Co | 7-HALO-Y 7ß, 8ß-METHANE-TAXOLES, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
| CA2161328A1 (en) * | 1993-06-11 | 1994-12-22 | Robert C. Kelly | Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them |
| IL112412A (en) * | 1994-01-28 | 2000-02-29 | Upjohn Co | Delta 12,13-iso-taxol analogs and antineoplastic pharmaceutical compositions containing them |
| CA2170661A1 (en) * | 1995-03-22 | 1996-09-23 | John K. Thottathil | Novel methods for the preparation of taxanes using oaxzolidine intermediates |
| EP1099696A3 (en) * | 1995-06-06 | 2001-05-23 | Dr. Reddy's Research Foundation | Preparation of oxazolidine |
| AU4768797A (en) * | 1996-10-24 | 1998-05-15 | Institute Armand-Frappier | A family of canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof |
| US6150537A (en) * | 1997-12-12 | 2000-11-21 | Emory University | Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents |
| TR200100575T2 (en) * | 1998-08-20 | 2001-07-23 | Aventis Pharma S.A. | New uses of taxoid derivatives |
| EP0982028A1 (en) * | 1998-08-20 | 2000-03-01 | Aventis Pharma S.A. | New use of taxoid derivatives |
| JP4502338B2 (en) * | 1999-09-17 | 2010-07-14 | 株式会社横浜国際バイオ研究所 | Method for producing taxoid compounds |
| WO2001024763A2 (en) | 1999-10-01 | 2001-04-12 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| WO2002012216A1 (en) * | 2000-08-08 | 2002-02-14 | Dr. Reddy's Research Foundation | An improved process for the preparation of docetaxel |
| JP2002088935A (en) | 2000-09-14 | 2002-03-27 | Nichiha Corp | Vertical-joint joiner for external facing material |
| US8338617B2 (en) | 2004-11-19 | 2012-12-25 | Dr. Reddy's Laboratories Limited | Process for preparing oxazolidine derivatives |
| CZ298332B6 (en) * | 2005-09-26 | 2007-08-29 | Zentiva, A. S | Process for preparing (4S,5R)-2,4-diphenyloxazoline-4,5-dihydro-5-carboxylic acid |
| AU2006331674A1 (en) * | 2005-12-21 | 2007-07-05 | Tapestry Pharmaceuticals, Inc. | Processes for taxane derivatives and intermediates useful therein |
| WO2008074178A1 (en) * | 2006-11-23 | 2008-06-26 | Shanghai Bailing Pharmaceutical Technology Co., Ltd | A new semisynthetic process of pacutaxel |
| CN101020672B (en) * | 2006-12-28 | 2010-08-25 | 上海百灵医药科技有限公司 | Process of synthesizing docetaxel |
| PL388144A1 (en) | 2009-05-29 | 2010-12-06 | Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością | (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate 4-acetoxy-2?-benzoiloxy-5� ,20-epoxy-1, 7�, 10�-trihydroxy-9-oxo-taks-11 -en-13?-yl solvates, a method for their production and application thereof |
| KR101379694B1 (en) * | 2011-09-30 | 2014-03-31 | 주식회사 삼양바이오팜 | Method for preparing taxane derivatives |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5977375A (en) * | 1992-10-05 | 1999-11-02 | Rhone-Poulenc Rorer S.A. | Esters of baccatin III and 10-deacetylbaccatin III |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2629819B1 (en) * | 1988-04-06 | 1990-11-16 | Rhone Poulenc Sante | PROCESS FOR THE PREPARATION OF BACCATIN III AND DESACETYL-10 BACCATIN III DERIVATIVES |
| MX9102128A (en) * | 1990-11-23 | 1992-07-08 | Rhone Poulenc Rorer Sa | DERIVATIVES OF TAXANE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM |
| FR2696459B1 (en) * | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Process for the preparation of taxane derivatives. |
| FR2696458B1 (en) * | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Process for the preparation of taxane derivatives. |
| FR2696460B1 (en) * | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Process for the preparation of taxane derivatives. |
| CA2161328A1 (en) * | 1993-06-11 | 1994-12-22 | Robert C. Kelly | Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them |
-
1992
- 1992-10-30 FR FR9213000A patent/FR2697522B1/en not_active Expired - Fee Related
-
1993
- 1993-10-25 MX MX9306606A patent/MX9306606A/en not_active IP Right Cessation
- 1993-10-27 ZA ZA938012A patent/ZA938012B/en unknown
- 1993-10-28 US US08/424,386 patent/US5686623A/en not_active Expired - Fee Related
- 1993-10-28 ES ES93924646T patent/ES2133418T3/en not_active Expired - Lifetime
- 1993-10-28 RU RU95111381/04A patent/RU2118958C1/en not_active IP Right Cessation
- 1993-10-28 KR KR1019950701766A patent/KR100255460B1/en not_active Expired - Fee Related
- 1993-10-28 PL PL93308638A patent/PL177746B1/en unknown
- 1993-10-28 EP EP93924646A patent/EP0666857B1/en not_active Expired - Lifetime
- 1993-10-28 AT AT93924646T patent/ATE180258T1/en not_active IP Right Cessation
- 1993-10-28 DK DK93924646T patent/DK0666857T3/en active
- 1993-10-28 AU AU54237/94A patent/AU679947B2/en not_active Ceased
- 1993-10-28 WO PCT/FR1993/001058 patent/WO1994010169A1/en not_active Ceased
- 1993-10-28 SK SK557-95A patent/SK281045B6/en unknown
- 1993-10-28 HU HU9501235A patent/HUT73780A/en unknown
- 1993-10-28 TW TW082109008A patent/TW427988B/en not_active IP Right Cessation
- 1993-10-28 DE DE69325031T patent/DE69325031T2/en not_active Expired - Fee Related
- 1993-10-28 CZ CZ19951092A patent/CZ287805B6/en not_active IP Right Cessation
- 1993-10-28 CA CA002148103A patent/CA2148103C/en not_active Expired - Fee Related
- 1993-10-28 RU RU98103160/04A patent/RU2188198C2/en not_active IP Right Cessation
- 1993-10-28 JP JP6510775A patent/JP3030088B2/en not_active Expired - Lifetime
- 1993-10-28 NZ NZ257578A patent/NZ257578A/en unknown
-
1995
- 1995-04-26 NO NO951587A patent/NO304114B1/en not_active IP Right Cessation
- 1995-04-28 FI FI952059A patent/FI109798B/en active
-
1997
- 1997-08-08 US US08/908,807 patent/US6433180B1/en not_active Expired - Fee Related
-
1998
- 1998-04-22 NO NO981813A patent/NO306062B1/en not_active IP Right Cessation
-
1999
- 1999-05-20 GR GR990400398T patent/GR3030268T3/en unknown
-
2002
- 2002-06-26 US US10/179,027 patent/US20030013889A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5977375A (en) * | 1992-10-05 | 1999-11-02 | Rhone-Poulenc Rorer S.A. | Esters of baccatin III and 10-deacetylbaccatin III |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6433180B1 (en) | Carboxylic acids for synthesis of taxane derivatives | |
| KR100311198B1 (en) | Manufacturing method of taxane derivative | |
| US5977375A (en) | Esters of baccatin III and 10-deacetylbaccatin III | |
| US5726318A (en) | Process for the preparation of taxane derivatives | |
| US4924011A (en) | Process for preparing taxol | |
| USRE34277E (en) | Process for preparing taxol | |
| JPH08501789A (en) | Method for producing taxane derivative | |
| JPH0686441B2 (en) | Method for preparing derivatives of baccatin 111 and 10-deacetyl baccatin 111 | |
| IL95436A (en) | Process for preparing the history of phenylisosarine | |
| IL208290A (en) | Process for the preparation of 10-deacetyl-bis-7, 10-trichloroacetylbaccatin iii and docetaxel | |
| NO327909B1 (en) | Process for the preparation of taxanes from 10-deacetylbaccatin III | |
| WO2003087077A1 (en) | A semi-synthetic process for the preparation of n debenzoylpaclitaxel | |
| EP1712552A1 (en) | Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |